drug1	drug2	strength	RR	severity	patients.fem.mal	description	color	onethousand	fdr
Mesalazine	Azathioprine	0.406	-1.29	Moderate	518 (244/274)	The metabolism of Azathioprine can be decreased when combined with Mesalazine.	#B2D0E5	50.8932352279437	0
Haloperidol	Biperiden	0.48	-3.059	Moderate	315 (86/229)		#A3C5DF	30.9485889899658	0
Digoxin	Carvedilol	0.444	-1.455	Moderate	34 (15/19)	Digoxin may increase the bradycardic activities of Carvedilol.	#B1CFE5	3.34048262113916	5.10961918205358e-76
Carbamazepine	Levetiracetam	0.477	-1.175	Moderate	269 (133/136)	The risk or severity of adverse effects can be increased when Carbamazepine is combined with Levetiracetam.	#B4D1E6	26.4291125025422	0
Indomethacin	Methotrexate	0.339	1.424	Major	261 (162/99)	The serum concentration of Methotrexate can be increased when it is combined with Indomethacin.	#F7B9B9	25.6431165916859	2.36791958794022e-275
Digoxin	Furosemide	0.503	1.068	Moderate	49 (27/22)	The risk or severity of adverse effects can be increased when Furosemide is combined with Digoxin.	#F9BCBC	4.81422495399468	1.26264596591656e-92
Omeprazole	Diazepam	0.487	1.241	Moderate	12748 (7492/5256)	The metabolism of Diazepam can be decreased when combined with Omeprazole.	#F8BABA	1252.48448394947	1
Amiodarone	Acenocoumarol	0.463	-2.106	None	51 (18/33)	The therapeutic efficacy of Acenocoumarol can be increased when used in combination with Amiodarone.	#ACCCE3	5.01072393170875	1.19740546085449e-100
Digoxin	Spironolactone	0.475	-1.768	Minor	33 (13/20)	The serum concentration of Digoxin can be increased when it is combined with Spironolactone.	#AECDE3	3.24223313228213	2.33116578201134e-71
Methotrexate	Hydroxychloroquine	0.319	6.428	Minor	109 (96/13)		#E48E8E	10.7091942854167	8.09851024866095e-129
Lamotrigine	Carbamazepine	0.459	-1.065	Moderate	158 (82/76)	The risk or severity of adverse effects can be increased when Lamotrigine is combined with Carbamazepine.	#B4D1E6	15.5234192394114	6.98934650402076e-160
Digoxin	Amiodarone	0.29	-1.723	Major	10 (4/6)	The serum concentration of Digoxin can be increased when it is combined with Amiodarone.	#AFCEE4	0.982494888570342	9.90846405590128e-21
Omeprazole	Alprazolam	0.32	1.536	Moderate	5930 (3785/2145)	The metabolism of Alprazolam can be decreased when combined with Omeprazole.	#F7B9B9	582.619468922213	1
Warfarin	Amiodarone	0.247	2.176	Major	7 (5/2)	The therapeutic efficacy of Warfarin can be increased when used in combination with Amiodarone.	#F5B2B2	0.68774642199924	2.4045450543757e-11
Trimethoprim	Leucovorin	0.61	-2.619	Major	246 (75/171)		#A8C8E1	24.1693742588304	0
Pravastatin	Fenofibrate	0.846	-4.716	Major	97 (19/78)	The risk or severity of myopathy and rhabdomyolysis can be increased when Fenofibrate is combined with Pravastatin.	#96BBD9	9.53020041913232	1.74716006690895e-142
Valproic acid	Carbamazepine	0.528	-2.044	Moderate	264 (95/169)	The serum concentration of the active metabolites of Carbamazepine can be increased when Carbamazepine is used in combination with Valproic Acid.	#ACCCE3	25.937865058257	1.07304380493818e-235
Ethinylestradiol	Amoxicillin	0.179	1172.229	Moderate	5391 (5387/4)		#B32020	529.662994428272	1
Fluvoxamine	Clomipramine	0.415	-2.164	Major	124 (43/81)	The risk or severity of adverse effects can be increased when Fluvoxamine is combined with Clomipramine.	#ABCBE2	12.1829366182722	4.94655966895944e-144
Haloperidol	Lithium cation	0.39	-1.547	Major	61 (26/35)	Lithium may increase the neurotoxic activities of Haloperidol.	#B1CFE5	5.99321882027909	3.66012813492573e-68
Propranolol	Rizatriptan	0.409	3.416	Moderate	261 (208/53)	The serum concentration of Rizatriptan can be increased when it is combined with Propranolol.	#F0A7A7	25.6431165916859	2.41625314528163e-133
Carbamazepine	Risperidone	0.401	-1.908	Moderate	157 (59/98)	The serum concentration of Risperidone can be decreased when it is combined with Carbamazepine.	#AECDE3	15.4251697505544	4.7604997998503e-118
Trihexyphenidyl	Haloperidol	0.674	-3.83	Moderate	26 (6/20)		#9DC0DC	2.55448671028289	6.07461493270461e-48
Omeprazole	Methotrexate	0.305	1.835	Major	715 (485/230)	The serum concentration of Methotrexate can be increased when it is combined with Omeprazole.	#F6B6B6	70.2483845327795	5.63001583367951e-49
Omeprazole	Clonazepam	0.323	-1.128	Moderate	1926 (972/954)		#B4D1E6	189.228515538648	1
Topiramate	Lithium cation	0.343	1.596	Moderate	119 (77/42)	The serum concentration of Lithium can be increased when it is combined with Topiramate.	#F7B7B7	11.6916891739871	1.15137294401006e-69
Mesalazine	Mercaptopurine	0.305	-1.061	Moderate	25 (13/12)	The metabolism of Mercaptopurine can be decreased when combined with Mesalazine.	#B4D1E6	2.45623722142586	3.80931434957656e-32
Fenofibrate	Atorvastatin	0.481	-3.447	Major	96 (24/72)	The risk or severity of myopathy and rhabdomyolysis can be increased when Fenofibrate is combined with Atorvastatin.	#A0C3DD	9.43195093027528	3.54323822720213e-75
Spironolactone	Enalapril	0.431	-1.273	Major	78 (37/41)	The risk or severity of adverse effects can be increased when Spironolactone is combined with Enalapril.	#B2D0E5	7.66346013084867	2.19937023248588e-60
Fluoxetine	Clomipramine	0.388	1.316	Major	221 (133/88)	The risk or severity of adverse effects can be increased when Fluoxetine is combined with Clomipramine.	#F8BABA	21.7131370374046	2.52892851685663e-74
Phenytoin	Vigabatrin	0.375	Inf	Minor	2 (2/0)	The serum concentration of Phenytoin can be decreased when it is combined with Vigabatrin.	#B32020	0.196498977714068	0.0763743270998418
Fluvoxamine	Olanzapine	0.386	-2.467	Moderate	107 (34/73)	The metabolism of Olanzapine can be decreased when combined with Fluvoxamine.	#A9C9E1	10.5126953077027	1.35977986217248e-78
Levothyroxine	Iron	0.237	143.444	Moderate	829 (824/5)	The serum concentration of Levothyroxine can be decreased when it is combined with Iron.	#B32020	81.4488262624814	1
Phenytoin	Lamotrigine	0.426	-2.708	Moderate	47 (14/33)	The serum concentration of Lamotrigine can be decreased when it is combined with Phenytoin.	#A6C7E0	4.61772597628061	2.1128559432507e-56
Topiramate	Carbamazepine	0.42	-1.114	Moderate	130 (66/64)	The serum concentration of Topiramate can be decreased when it is combined with Carbamazepine.	#B4D1E6	12.7724335514144	2.82395262650076e-59
Repaglinide	Gliclazide	0.301	-2.298	None	12 (4/8)	Repaglinide may increase the hypoglycemic activities of Gliclazide.	#A9C9E1	1.17899386628441	7.5114705503666e-17
Ramipril	Spironolactone	0.435	-1.776	Major	28 (11/17)	The risk or severity of adverse effects can be increased when Ramipril is combined with Spironolactone.	#AECDE3	2.75098568799696	4.89798651682017e-31
Haloperidol	Carbamazepine	0.418	-2.433	Moderate	53 (17/36)	The metabolism of Haloperidol can be increased when combined with Carbamazepine.	#A9C9E1	5.20722290942281	2.32779661955441e-46
Rifabutin	Warfarin	0.391	Inf	None	1 (1/0)	The metabolism of Warfarin can be increased when combined with Rifabutin.	#B32020	0.0982494888570342	1
Megestrol acetate	Primidone	0.125	Inf	Moderate	1 (1/0)		#B32020	0.0982494888570342	1
Dapsone	Trimethoprim	0.733	Inf	Moderate	3 (3/0)	The risk or severity of adverse effects can be increased when Trimethoprim is combined with Dapsone.	#B32020	0.294748466571103	0.0363116743674618
Cyclosporine	Sulfamethoxazole	0.303	-1.27	Major	40 (19/21)	Sulfamethoxazole may increase the nephrotoxic activities of Cyclosporine.	#B2D0E5	3.92997955428137	3.36252511060738e-31
Amitriptyline	Duloxetine	0.38	3.752	Major	154 (125/29)	Duloxetine may increase the serotonergic activities of Amitriptyline.	#EFA6A6	15.1304212839833	8.33482430383269e-22
Fluvoxamine	Lithium cation	0.482	1.306	Major	25 (15/10)	Lithium may increase the serotonergic activities of Fluvoxamine.	#F8BABA	2.45623722142586	1.15716321363158e-16
Tacrolimus	Atorvastatin	0.413	-2.333	Moderate	100 (33/67)	The risk or severity of adverse effects can be increased when Tacrolimus is combined with Atorvastatin.	#A9C9E1	9.82494888570342	2.12537594048107e-53
Acetylsalicylic acid	Insulin aspart	0.257	1.098	Moderate	147 (82/65)	Acetylsalicylic acid may increase the hypoglycemic activities of Insulin Aspart.	#F9BCBC	14.442674861984	5.75403535519891e-28
Fluoxetine	Risperidone	0.405	-2.122	Moderate	242 (85/157)	The metabolism of Risperidone can be decreased when combined with Fluoxetine.	#ABCBE2	23.7763763034023	2.67618763787483e-53
Spironolactone	Captopril	0.448	1.451	Major	8 (5/3)	The risk or severity of adverse effects can be increased when Spironolactone is combined with Captopril.	#F7B9B9	0.785995910856274	7.00568150327668e-08
Methadone	Naltrexone	0.25	Inf	Major	1 (1/0)	The therapeutic efficacy of Methadone can be decreased when used in combination with Naltrexone.	#B32020	0.0982494888570342	1
Methotrexate	Naproxen	0.285	1.864	Major	267 (182/85)	The serum concentration of Methotrexate can be increased when it is combined with Naproxen.	#F6B6B6	26.2326135248281	1
Spironolactone	Losartan	0.331	1.243	Major	17 (10/7)	The risk or severity of adverse effects can be increased when Spironolactone is combined with Losartan.	#F8BABA	1.67024131056958	4.74614434324641e-13
Pyridostigmine	Prednisone	0.374	2.928	Moderate	48 (37/11)	The risk or severity of adverse effects can be increased when Prednisone is combined with Pyridostigmine.	#F2ACAC	4.71597546513764	1.69405189316522e-22
Prednisone	Ethinylestradiol	0.19	291.588	Moderate	672 (670/2)	The serum concentration of Prednisone can be increased when it is combined with Ethinyl Estradiol.	#B32020	66.023656511927	1
Acetaminophen	Acenocoumarol	0.243	-1.134	None	475 (239/236)	Acetaminophen may increase the anticoagulant activities of Acenocoumarol.	#B4D1E6	46.6685072070913	1
Clozapine	Haloperidol	0.301	-3.83	Major	13 (3/10)	Clozapine may increase the QTc-prolonging activities of Haloperidol.	#9DC0DC	1.27724335514144	6.21507827755087e-15
Phenytoin	Dexamethasone	0.441	-1.436	Moderate	18 (8/10)	The serum concentration of Dexamethasone can be decreased when it is combined with Phenytoin.	#B1CFE5	1.76849079942662	1.81488400546157e-13
Carbamazepine	Midazolam	0.213	1.368	Moderate	18 (11/7)	The metabolism of Midazolam can be increased when combined with Carbamazepine.	#F8BABA	1.76849079942662	3.73984873284355e-11
Cyclosporine	Colchicine	0.311	-2.298	Major	12 (4/8)	The serum concentration of Colchicine can be increased when it is combined with Cyclosporine.	#A9C9E1	1.17899386628441	5.7116579090992e-10
Propranolol	Ibuprofen	0.31	2.041	Moderate	806 (565/241)	Ibuprofen may decrease the antihypertensive activities of Propranolol.	#F5B4B4	79.1890880187696	1
Simvastatin	Fenofibrate	0.48	-5.623	Major	112 (19/93)	The risk or severity of myopathy and rhabdomyolysis can be increased when Fenofibrate is combined with Simvastatin.	#90B6D6	11.0039427519878	3.30501332942494e-55
Amitriptyline	Fluoxetine	0.411	4.501	Major	216 (181/35)	The risk or severity of adverse effects can be increased when Fluoxetine is combined with Amitriptyline.	#EC9F9F	21.2218895931194	1
Prednisone	Acetylsalicylic acid	0.417	2.176	Moderate	322 (230/92)	The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Prednisone.	#F5B2B2	31.636335411965	1
Fenofibrate	Rosuvastatin	0.556	-4.366	Major	24 (5/19)	The risk or severity of myopathy and rhabdomyolysis can be increased when Fenofibrate is combined with Rosuvastatin.	#99BDDA	2.35798773256882	3.89173527131548e-21
Diltiazem	Sirolimus	0.182	Inf	Moderate	1 (1/0)	The metabolism of Sirolimus can be decreased when combined with Diltiazem.	#B32020	0.0982494888570342	1
Fluoxetine	Propranolol	0.388	2.794	Moderate	160 (122/38)	The metabolism of Propranolol can be decreased when combined with Fluoxetine.	#F2AEAE	15.7199182171255	0.00018055152855336
Fluoxetine	Lithium cation	0.36	1.161	Major	91 (52/39)	Lithium may increase the serotonergic activities of Fluoxetine.	#F9BCBC	8.94070348599011	8.54319147083066e-20
Propranolol	Paroxetine	0.357	2.059	Moderate	212 (149/63)	The metabolism of Propranolol can be decreased when combined with Paroxetine.	#F5B4B4	20.8288916376913	1
Paroxetine	Risperidone	0.368	-2.27	Moderate	247 (83/164)	The metabolism of Risperidone can be decreased when combined with Paroxetine.	#ABCBE2	24.2676237476875	9.23228419774128e-20
Atorvastatin	Gemfibrozil	0.448	-3.529	Major	57 (14/43)	The risk or severity of adverse effects can be increased when Gemfibrozil is combined with Atorvastatin.	#A0C3DD	5.60022086485095	8.38374401828755e-20
Risperidone	Donepezil	0.516	-1.149	Moderate	2 (1/1)		#B4D1E6	0.196498977714068	0.686633567438628
Fluorouracil	Warfarin	0.024	Inf	Major	1 (1/0)	The serum concentration of Warfarin can be increased when it is combined with Fluorouracil.	#B32020	0.0982494888570342	1
Phenytoin	Warfarin	0.214	Inf	Moderate	2 (2/0)	Phenytoin may increase the anticoagulant activities of Warfarin.	#B32020	0.196498977714068	1
Cyclosporine	Omeprazole	0.34	-1.175	Moderate	176 (87/89)	The serum concentration of Cyclosporine can be increased when it is combined with Omeprazole.	#B4D1E6	17.291910038838	0.0457508449654853
Verapamil	Eplerenone	0.091	Inf	Moderate	1 (1/0)	The serum concentration of Eplerenone can be increased when it is combined with Verapamil.	#B32020	0.0982494888570342	1
Acetylsalicylic acid	Ibuprofen	0.371	1.22	Major	975 (569/406)	The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Ibuprofen.	#F8BABA	95.7932516356084	1
Omeprazole	Ketazolam	0.411	1.223	None	303 (177/126)		#F8BABA	29.7695951236814	1
Pyridostigmine	Fludrocortisone	0.205	Inf	Moderate	2 (2/0)	The risk or severity of adverse effects can be increased when Fludrocortisone is combined with Pyridostigmine.	#B32020	0.196498977714068	0.688036736051553
Atenolol	Prazosin	0.25	Inf	Moderate	1 (1/0)	Atenolol may increase the orthostatic hypotensive activities of Prazosin.	#B32020	0.0982494888570342	1
Cyclosporine	Tacrolimus	0.198	-1.567	Major	26 (11/15)	Tacrolimus may increase the nephrotoxic activities of Cyclosporine.	#AFCEE4	2.55448671028289	8.09206137473205e-16
Tramadol	Citalopram	0.269	2.223	Major	327 (235/92)	Citalopram may increase the neuroexcitatory activities of Tramadol.	#F5B2B2	32.1275828562502	1
Spironolactone	Benazepril	0.75	-1.149	Major	2 (1/1)	The risk or severity of adverse effects can be increased when Spironolactone is combined with Benazepril.	#B4D1E6	0.196498977714068	0.0820240892901799
Tramadol	Fluoxetine	0.251	3.086	Major	250 (195/55)	Fluoxetine may increase the neuroexcitatory activities of Tramadol.	#F1ABAB	24.5623722142586	1
Amiodarone	Flecainide	0.567	-3.447	Major	4 (1/3)	The serum concentration of Flecainide can be increased when it is combined with Amiodarone.	#A0C3DD	0.392997955428137	0.000219151319314888
Phenytoin	Oxcarbazepine	0.398	-2.987	Moderate	18 (5/13)	The serum concentration of the active metabolites of Oxcarbazepine can be reduced when Oxcarbazepine is used in combination with Phenytoin resulting in a loss in efficacy.	#A5C6DF	1.76849079942662	9.07559258711429e-14
Citalopram	Propranolol	0.359	1.655	Moderate	177 (116/61)	The metabolism of Propranolol can be decreased when combined with Citalopram.	#F7B7B7	17.3901595276951	1
Sucralfate	Lansoprazole	0.49	-1.368	Moderate	46 (21/25)		#B2D0E5	4.51947648742357	3.34295588542037e-17
Tramadol	Paroxetine	0.27	2.195	Major	317 (227/90)	Paroxetine may increase the neuroexcitatory activities of Tramadol.	#F5B2B2	31.1450879676798	1
Alprazolam	Clarithromycin	0.284	1.97	Moderate	545 (378/167)	The serum concentration of Alprazolam can be increased when it is combined with Clarithromycin.	#F5B4B4	53.5459714270836	1
Propranolol	Escitalopram	0.315	1.352	None	143 (87/56)		#F8BABA	14.0496769065559	0.179964660792388
Sumatriptan	Ergotamine	0.649	2.708	Major	37 (28/9)	Ergotamine may increase the vasoconstricting activities of Sumatriptan.	#F2AEAE	3.63523108771027	2.16357592830113e-10
Sulfasalazine	Mercaptopurine	0.377	Inf	Moderate	2 (2/0)		#B32020	0.196498977714068	1
Prednisone	Estradiol	0.171	201.936	Moderate	233 (232/1)	The serum concentration of Prednisone can be increased when it is combined with Estradiol.	#B32020	22.892130903689	1
Propranolol	Sertraline	0.384	1.34	Moderate	127 (77/50)	The metabolism of Propranolol can be decreased when combined with Sertraline.	#F8BABA	12.4776850848433	0.000926973077527955
Carbamazepine	Simvastatin	0.274	-1.746	Moderate	63 (25/38)	The metabolism of Simvastatin can be increased when combined with Carbamazepine.	#AECDE3	6.18971779799316	9.55899516932497e-11
Azathioprine	Acenocoumarol	0.444	2.394	None	15 (11/4)	Azathioprine may decrease the anticoagulant activities of Acenocoumarol.	#F4B1B1	1.47374233285551	0.000339836520218643
Cyclosporine	Atorvastatin	0.455	-1.149	Major	16 (8/8)	The serum concentration of Atorvastatin can be increased when it is combined with Cyclosporine.	#B4D1E6	1.57199182171255	3.00149933610549e-06
Zolmitriptan	Ergotamine	0.561	6.528	Major	34 (30/4)	Ergotamine may increase the vasoconstricting activities of Zolmitriptan.	#E48E8E	3.34048262113916	1.72863201724629e-06
Amitriptyline	Carbamazepine	0.383	2.031	Moderate	60 (42/18)	The metabolism of Amitriptyline can be increased when combined with Carbamazepine.	#F5B4B4	5.89496933142205	0.00729179408039162
Methotrexate	Flurbiprofen	0.237	-1.149	Major	6 (3/3)	The serum concentration of Methotrexate can be increased when it is combined with Flurbiprofen.	#B4D1E6	0.589496933142205	2.77064741539626e-05
Ergotamine	Rizatriptan	0.545	2.901	Major	39 (30/9)	Ergotamine may increase the vasoconstricting activities of Rizatriptan.	#F2ACAC	3.83173006542433	3.78760694268913e-09
Digoxin	Hydrochlorothiazide	0.329	1.088	Moderate	9 (5/4)	The risk or severity of adverse effects can be increased when Hydrochlorothiazide is combined with Digoxin.	#F9BCBC	0.884245399713308	1.0809965838992e-05
Carbamazepine	Aripiprazole	0.377	-1.685	Moderate	37 (15/22)	The serum concentration of Aripiprazole can be decreased when it is combined with Carbamazepine.	#AFCEE4	3.63523108771027	1.80871417567713e-12
Fluconazole	Alprazolam	0.277	3.564	Major	377 (303/74)	The metabolism of Alprazolam can be decreased when combined with Fluconazole.	#F0A7A7	37.0400572991019	1
Mirtazapine	Clonidine	0.227	2.611	Moderate	4 (3/1)	Mirtazapine may decrease the antihypertensive activities of Clonidine.	#F3AFAF	0.392997955428137	0.474439185114112
Ethinylestradiol	Itraconazole	0.238	181.916	Moderate	210 (209/1)	The metabolism of Ethinyl Estradiol can be decreased when combined with Itraconazole.	#B32020	20.6323926599772	1
Glimepiride	Repaglinide	1	-1.149	None	2 (1/1)	Glimepiride may increase the hypoglycemic activities of Repaglinide.	#B4D1E6	0.196498977714068	0.775173928682573
Venlafaxine	Metoclopramide	0.195	3.15	Moderate	194 (152/42)	The risk or severity of adverse effects can be increased when Metoclopramide is combined with Venlafaxine.	#F1ABAB	19.0604008382646	1
Clozapine	Clonazepam	0.395	-4.924	Moderate	37 (7/30)	The risk or severity of adverse effects can be increased when Clonazepam is combined with Clozapine.	#94B9D8	3.63523108771027	6.13733064369064e-27
Spironolactone	Irbesartan	0.433	-1.149	Major	6 (3/3)	The risk or severity of adverse effects can be increased when Spironolactone is combined with Irbesartan.	#B4D1E6	0.589496933142205	0.000363713633701969
Diltiazem	Amiodarone	1	Inf	Major	1 (1/0)	The risk or severity of bradycardia can be increased when Diltiazem is combined with Amiodarone.	#B32020	0.0982494888570342	1
Acetylsalicylic acid	Acenocoumarol	0.396	-1.58	None	57 (24/33)	Acetylsalicylic acid may increase the anticoagulant activities of Acenocoumarol.	#AFCEE4	5.60022086485095	2.98708994786081e-14
Ziprasidone	Carbamazepine	0.394	-1.532	Minor	14 (6/8)	The serum concentration of Ziprasidone can be decreased when it is combined with Carbamazepine.	#B1CFE5	1.37549284399848	1.60066273313984e-07
Cyclosporine	Fluvastatin	0.146	Inf	Moderate	2 (2/0)	The serum concentration of Fluvastatin can be increased when it is combined with Cyclosporine.	#B32020	0.196498977714068	1
Carvedilol	Insulin aspart	0.261	2.321	Moderate	11 (8/3)		#F4B1B1	1.08074437742738	0.0466375944931383
Fluoxetine	Nortriptyline	0.29	2.089	Major	17 (12/5)	The risk or severity of adverse effects can be increased when Fluoxetine is combined with Nortriptyline.	#F5B4B4	1.67024131056958	7.23431603386595e-06
Cyclosporine	Sirolimus	0.095	-1.149	Moderate	2 (1/1)	The risk or severity of adverse effects can be increased when Sirolimus is combined with Cyclosporine.	#B4D1E6	0.196498977714068	0.901982522600397
Sulfasalazine	Azathioprine	0.312	-2.681	Moderate	20 (6/14)		#A6C7E0	1.96498977714068	1.99386327774939e-16
Fluvoxamine	Mirtazapine	0.329	-1.915	Major	40 (15/25)	The risk or severity of adverse effects can be increased when Fluvoxamine is combined with Mirtazapine.	#AECDE3	3.92997955428137	2.99264637669456e-13
Omeprazole	Itraconazole	0.386	1.291	Moderate	519 (310/209)	The serum concentration of Itraconazole can be decreased when it is combined with Omeprazole.	#F8BABA	50.9914847168008	1
Tramadol	Escitalopram	0.243	1.569	Major	213 (137/76)	Escitalopram may increase the neuroexcitatory activities of Tramadol.	#F7B7B7	20.9271411265483	1
Acetylsalicylic acid	Methylprednisolone	0.622	3.482	Moderate	60 (48/12)	The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Methylprednisolone.	#F0A7A7	5.89496933142205	1
Prednisone	Acenocoumarol	0.282	1.213	None	79 (46/33)		#F8BABA	7.7617096197057	1
Cyclosporine	Sulfadiazine	0.02	Inf	Major	1 (1/0)	Sulfadiazine may increase the nephrotoxic activities of Cyclosporine.	#B32020	0.0982494888570342	1
Trospium	Oxybutynin	0.793	Inf	Moderate	1 (1/0)	The risk or severity of adverse effects can be increased when Trospium is combined with Oxybutynin.	#B32020	0.0982494888570342	1
Methotrexate	Phenylbutazone	0.105	-1.149	Major	4 (2/2)	The serum concentration of Methotrexate can be increased when it is combined with Phenylbutazone.	#B4D1E6	0.392997955428137	0.0092343820182408
Digoxin	Verapamil	0.125	Inf	Moderate	1 (1/0)	The metabolism of Digoxin can be decreased when combined with Verapamil.	#B32020	0.0982494888570342	1
Imipramine	Duloxetine	0.322	1.741	Major	12 (8/4)	Duloxetine may increase the serotonergic activities of Imipramine.	#F7B7B7	1.17899386628441	4.49464430209976e-05
Phenytoin	Clozapine	0.212	Inf	Moderate	1 (1/0)	The serum concentration of Clozapine can be decreased when it is combined with Phenytoin.	#B32020	0.0982494888570342	1
Propranolol	Ergotamine	0.517	4.352	Moderate	30 (25/5)	Ergotamine may increase the atrioventricular blocking (AV block) activities of Propranolol.	#EC9F9F	2.94748466571103	0.00809577087368802
Bisoprolol	Ibuprofen	0.206	-1.109	Moderate	344 (175/169)	Ibuprofen may decrease the antihypertensive activities of Bisoprolol.	#B4D1E6	33.7978241668198	1
Allopurinol	Acenocoumarol	0.376	-2.987	None	18 (5/13)	Allopurinol may increase the anticoagulant activities of Acenocoumarol.	#A5C6DF	1.76849079942662	1.2163486625853e-06
Clozapine	Flunitrazepam	0.514	-3.447	None	4 (1/3)	The risk or severity of adverse effects can be increased when Flunitrazepam is combined with Clozapine.	#A0C3DD	0.392997955428137	0.00120222593693497
Paroxetine	Rizatriptan	0.259	5.048	Major	102 (87/15)	The risk or severity of adverse effects can be increased when Paroxetine is combined with Rizatriptan.	#EA9B9B	10.0214478634175	1
Ibuprofen	Lithium cation	0.124	-1.09	Moderate	267 (137/130)	The serum concentration of Lithium can be increased when it is combined with Ibuprofen.	#B4D1E6	26.2326135248281	1
Amitriptyline	Salbutamol	0.254	2.806	Moderate	245 (187/58)	The risk or severity of adverse effects can be increased when Amitriptyline is combined with Salbutamol.	#F2AEAE	24.0711247699734	1
Atenolol	Ibuprofen	0.237	-1.246	Moderate	344 (165/179)	Ibuprofen may decrease the antihypertensive activities of Atenolol.	#B2D0E5	33.7978241668198	1
Cyclosporine	Methotrexate	0.184	-1.723	Moderate	15 (6/9)	The serum concentration of Methotrexate can be increased when it is combined with Cyclosporine.	#AFCEE4	1.47374233285551	2.77049659579681e-08
Alprazolam	Carbamazepine	0.275	1.032	Moderate	118 (64/54)	The metabolism of Alprazolam can be increased when combined with Carbamazepine.	#F9BCBC	11.59343968513	1
Phenytoin	Quetiapine	0.269	1.044	Major	11 (6/5)	The serum concentration of Quetiapine can be decreased when it is combined with Phenytoin.	#F9BCBC	1.08074437742738	0.187041051685157
Tramadol	Carbamazepine	0.39	1.306	Moderate	70 (42/28)	Tramadol may increase the central nervous system depressant (CNS depressant) activities of Carbamazepine.	#F8BABA	6.8774642199924	1
Diltiazem	Simvastatin	0.743	-1.149	Major	12 (6/6)	The serum concentration of Simvastatin can be increased when it is combined with Diltiazem.	#B4D1E6	1.17899386628441	0.00322180264616462
Pimozide	Sertraline	0.343	1.306	Major	10 (6/4)	Sertraline may increase the QTc-prolonging activities of Pimozide.	#F8BABA	0.982494888570342	0.00869053411517751
Omeprazole	Midazolam	0.274	1.183	Moderate	92 (53/39)		#F9BCBC	9.03895297484715	1
Zolmitriptan	Paroxetine	0.273	7.64	Major	88 (79/9)	The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Paroxetine.	#E08585	8.64595501941901	1
Chlorthalidone	Digoxin	0.297	-1.149	Moderate	2 (1/1)	The risk or severity of adverse effects can be increased when Chlorthalidone is combined with Digoxin.	#B4D1E6	0.196498977714068	0.612057031684606
Repaglinide	Glyburide	0.214	-2.298	None	3 (1/2)	Repaglinide may increase the hypoglycemic activities of Glyburide.	#A9C9E1	0.294748466571103	0.0598364928183417
Ziprasidone	Pimozide	0.1	Inf	Major	1 (1/0)	The serum concentration of Pimozide can be increased when it is combined with Ziprasidone.	#B32020	0.0982494888570342	1
Ibuprofen	Nadolol	0.353	3.649	Moderate	135 (109/26)	Ibuprofen may decrease the antihypertensive activities of Nadolol.	#EFA6A6	13.2636809956996	1
Carbamazepine	Sertraline	0.357	-1.559	Moderate	66 (28/38)	The metabolism of Carbamazepine can be decreased when combined with Sertraline.	#AFCEE4	6.48446626456426	5.75011820450284e-05
Rizatriptan	Escitalopram	0.286	4.669	Major	70 (59/11)	The risk or severity of adverse effects can be increased when Rizatriptan is combined with Escitalopram.	#EB9E9E	6.8774642199924	1
Citalopram	Rizatriptan	0.267	8.269	Major	84 (76/8)	The risk or severity of adverse effects can be increased when Citalopram is combined with Rizatriptan.	#DD7E7E	8.25295706399088	1
Methotrexate	Amoxicillin	0.176	1.977	Major	229 (159/70)	The serum concentration of Methotrexate can be increased when it is combined with Amoxicillin.	#F5B4B4	22.4991329482608	1
Diazepam	Clarithromycin	0.429	1.762	Moderate	505 (338/167)	The metabolism of Diazepam can be decreased when combined with Clarithromycin.	#F6B6B6	49.6159918728023	1
Acetylsalicylic acid	Glipizide	1	-2.298	Moderate	3 (1/2)	Acetylsalicylic acid may increase the hypoglycemic activities of Glipizide.	#A9C9E1	0.294748466571103	0.128334857772243
Dextromethorphan	Paroxetine	0.201	2.307	Major	219 (159/60)	Paroxetine may increase the serotonergic activities of Dextromethorphan.	#F4B1B1	21.5166380596905	1
Carbamazepine	Atorvastatin	0.209	-2.716	Moderate	37 (11/26)	The metabolism of Atorvastatin can be increased when combined with Carbamazepine.	#A6C7E0	3.63523108771027	6.54469306163432e-10
Zolmitriptan	Escitalopram	0.242	4.134	Major	69 (57/12)	The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Escitalopram.	#EDA3A3	6.77921473113536	1
Cyclosporine	Allopurinol	0.259	-4.596	Moderate	15 (3/12)		#97BCD9	1.47374233285551	1.6384479106214e-08
Citalopram	Clarithromycin	0.237	2.29	Major	236 (171/65)	Clarithromycin may increase the QTc-prolonging activities of Citalopram.	#F5B2B2	23.1868793702601	1
Spironolactone	Tolevamer	0.175	-1.149	Moderate	2 (1/1)		#B4D1E6	0.196498977714068	1
Doxycycline	Ethinylestradiol	0.305	Inf	Moderate	143 (143/0)	The metabolism of Ethinyl Estradiol can be decreased when combined with Doxycycline.	#B32020	14.0496769065559	1
Methotrexate	Ibuprofen	0.23	2.092	Major	211 (149/62)	The serum concentration of Methotrexate can be increased when it is combined with Ibuprofen.	#F5B4B4	20.7306421488342	1
Fluvoxamine	Nortriptyline	0.185	1.741	Major	3 (2/1)	The risk or severity of adverse effects can be increased when Fluvoxamine is combined with Nortriptyline.	#F7B7B7	0.294748466571103	1
Fluvoxamine	Carbamazepine	0.349	-1.313	Moderate	15 (7/8)	The metabolism of Carbamazepine can be decreased when combined with Fluvoxamine.	#B2D0E5	1.47374233285551	0.000522891386891277
Fluconazole	Diazepam	0.388	2.978	Moderate	367 (284/83)	The metabolism of Diazepam can be decreased when combined with Fluconazole.	#F2ACAC	36.0575624105316	1
Gliclazide	Carvedilol	0.428	-1.723	None	5 (2/3)	Carvedilol may increase the hypoglycemic activities of Gliclazide.	#AFCEE4	0.491247444285171	0.0222453084074268
Repaglinide	Gemfibrozil	0.346	-2.298	Major	6 (2/4)	The serum concentration of Repaglinide can be increased when it is combined with Gemfibrozil.	#A9C9E1	0.589496933142205	0.117806615609385
Methotrexate	Acetylsalicylic acid	0.279	2.984	Major	31 (24/7)	The serum concentration of Methotrexate can be increased when it is combined with Acetylsalicylic acid.	#F2ACAC	3.04573415456806	1
Omeprazole	Flurazepam	0.263	-1.345	Moderate	89 (41/48)		#B2D0E5	8.74420450827605	1
Topiramate	Ethinylestradiol	0.219	Inf	Moderate	116 (116/0)	The serum concentration of Ethinyl Estradiol can be decreased when it is combined with Topiramate.	#B32020	11.396940707416	1
Fluoxetine	Rizatriptan	0.305	8.559	Major	65 (59/6)	The risk or severity of adverse effects can be increased when Fluoxetine is combined with Rizatriptan.	#DC7D7D	6.38621677570722	1
Phenytoin	Omeprazole	0.372	-2.441	Moderate	100 (32/68)	The serum concentration of Omeprazole can be decreased when it is combined with Phenytoin.	#A9C9E1	9.82494888570342	1
Spironolactone	Telmisartan	0.253	-1.723	Major	5 (2/3)	The risk or severity of adverse effects can be increased when Spironolactone is combined with Telmisartan.	#AFCEE4	0.491247444285171	0.00688497602775616
Zolmitriptan	Fluoxetine	0.217	8.124	Major	62 (56/6)	The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Fluoxetine.	#DE8080	6.09146830913612	1
Simvastatin	Gemfibrozil	0.341	-6.371	Major	72 (11/61)	The risk or severity of rhabdomyolysis. myoglobinuria. and elevated creatine kinase (CPK) can be increased when Gemfibrozil is combined with Simvastatin.	#89B1D3	7.07396319770646	3.28983692869841e-10
Furosemide	Ibuprofen	0.376	2.067	Moderate	189 (133/56)	The therapeutic efficacy of Furosemide can be decreased when used in combination with Ibuprofen.	#F5B4B4	18.5691533939795	1
Acetaminophen	Warfarin	0.26	-1.395	Minor	93 (42/51)	Acetaminophen may increase the anticoagulant activities of Warfarin.	#B1CFE5	9.13720246370418	1
Ergotamine	Almotriptan	0.491	11.315	Major	14 (13/1)	Ergotamine may increase the vasoconstricting activities of Almotriptan.	#D26565	1.37549284399848	0.226634492928031
Fluoxetine	Dextromethorphan	0.226	3.201	Major	145 (114/31)	Fluoxetine may increase the serotonergic activities of Dextromethorphan.	#F1ABAB	14.24617588427	1
Alprazolam	Itraconazole	0.286	2.168	Major	185 (132/53)	The serum concentration of Alprazolam can be increased when it is combined with Itraconazole.	#F5B2B2	18.1761554385513	1
Citalopram	Zolmitriptan	0.27	6.963	Major	72 (64/8)	The risk or severity of adverse effects can be increased when Citalopram is combined with Zolmitriptan.	#E28989	7.07396319770646	1
Norethisterone	Primidone	0.053	Inf	None	1 (1/0)	The metabolism of Norethisterone can be increased when combined with Primidone.	#B32020	0.0982494888570342	1
Sumatriptan	Paroxetine	0.277	5.706	Major	68 (59/9)	The risk or severity of adverse effects can be increased when Sumatriptan is combined with Paroxetine.	#E79494	6.68096524227833	1
Fluvastatin	Acenocoumarol	0.38	Inf	None	2 (2/0)	The metabolism of Acenocoumarol can be decreased when combined with Fluvastatin.	#B32020	0.196498977714068	1
Ibuprofen	Acenocoumarol	0.18	1.044	None	176 (96/80)	Ibuprofen may increase the anticoagulant activities of Acenocoumarol.	#F9BCBC	17.291910038838	1
Acetaminophen	Isoniazid	0.308	-1.255	Moderate	226 (108/118)	The risk or severity of adverse effects can be increased when Isoniazid is combined with Acetaminophen.	#B2D0E5	22.2043844816897	1
Doxycycline	Amoxicillin	0.528	1.029	Moderate	574 (311/263)	The therapeutic efficacy of Amoxicillin can be decreased when used in combination with Doxycycline.	#F9BCBC	56.3952066039376	1
Phenoxymethylpenicillin	Ethinylestradiol	0.185	Inf	Moderate	127 (127/0)		#B32020	12.4776850848433	1
Fluconazole	Clonazepam	0.2	4.414	None	85 (71/14)	The metabolism of Clonazepam can be decreased when combined with Fluconazole.	#EC9F9F	8.35120655284791	1
Paroxetine	Selegiline	0.153	1.741	Major	3 (2/1)	The risk or severity of adverse effects can be increased when Paroxetine is combined with Selegiline.	#F7B7B7	0.294748466571103	1
Acetylsalicylic acid	Insulin detemir	0.323	-1.436	Moderate	27 (12/15)	Acetylsalicylic acid may increase the hypoglycemic activities of Insulin Detemir.	#B1CFE5	2.65273619913992	3.62760616930961e-05
Phenytoin	Conjugated estrogens	0.14	Inf	Moderate	1 (1/0)	The therapeutic efficacy of Conjugated estrogens can be decreased when used in combination with Phenytoin.	#B32020	0.0982494888570342	1
Cyclosporine	Sevelamer	0.076	-1.149	Moderate	2 (1/1)	The serum concentration of Cyclosporine can be decreased when it is combined with Sevelamer.	#B4D1E6	0.196498977714068	1
Imipramine	Fluoxetine	0.347	1.915	Major	16 (11/5)	The risk or severity of adverse effects can be increased when Fluoxetine is combined with Imipramine.	#F6B6B6	1.57199182171255	0.0738067604875554
Almotriptan	Escitalopram	0.275	13.927	Major	34 (32/2)	The risk or severity of adverse effects can be increased when Almotriptan is combined with Escitalopram.	#C84F4F	3.34048262113916	1
Dihydroergotamine	Almotriptan	0.591	7.834	Major	10 (9/1)	Dihydroergotamine may increase the vasoconstricting activities of Almotriptan.	#DF8383	0.982494888570342	0.432108087231572
Atomoxetine	Haloperidol	0.48	-1.149	Major	2 (1/1)	The metabolism of Haloperidol can be decreased when combined with Atomoxetine.	#B4D1E6	0.196498977714068	1
Ezetimibe	Cholestyramine	0.188	-2.872	Moderate	7 (2/5)	Cholestyramine can cause a decrease in the absorption of Ezetimibe resulting in a reduced serum concentration and potentially a decrease in efficacy.	#A5C6DF	0.68774642199924	9.01997533106521e-05
Tizanidine	Ethinylestradiol	0.163	Inf	Major	78 (78/0)		#B32020	7.66346013084867	1
Alendronic acid	Ibuprofen	0.249	2.422	Moderate	87 (64/23)	The risk or severity of adverse effects can be increased when Ibuprofen is combined with Alendronic acid.	#F4B1B1	8.54770553056198	1
Cyclosporine	Pravastatin	0.526	-3.447	Major	8 (2/6)	The serum concentration of Pravastatin can be increased when it is combined with Cyclosporine.	#A0C3DD	0.785995910856274	4.46222358092805e-05
Pimozide	Escitalopram	0.397	-1.149	Major	10 (5/5)	The risk or severity of QTc prolongation can be increased when Pimozide is combined with Escitalopram.	#B4D1E6	0.982494888570342	0.0763971625869755
Valproic acid	Acetylsalicylic acid	0.261	-1.988	Moderate	71 (26/45)	The serum concentration of Valproic Acid can be increased when it is combined with Acetylsalicylic acid.	#ACCCE3	6.97571370884943	1
Atenolol	Clonidine	0.793	-1.149	Major	2 (1/1)	Clonidine may increase the atrioventricular blocking (AV block) activities of Atenolol.	#B4D1E6	0.196498977714068	1
Paroxetine	Almotriptan	0.269	6.963	Major	45 (40/5)	The metabolism of Almotriptan can be decreased when combined with Paroxetine.	#E28989	4.42122699856654	1
Nabumetone	Alendronic acid	0.059	Inf	Moderate	2 (2/0)	The risk or severity of adverse effects can be increased when Nabumetone is combined with Alendronic acid.	#B32020	0.196498977714068	1
Carvedilol	Insulin detemir	0.75	Inf	Moderate	2 (2/0)		#B32020	0.196498977714068	1
Colestipol	Ursodeoxycholic acid	0.875	Inf	None	1 (1/0)	The serum concentration of Ursodeoxycholic acid can be decreased when it is combined with Colestipol.	#B32020	0.0982494888570342	1
Phenytoin	Fludrocortisone	0.783	Inf	Moderate	1 (1/0)	The serum concentration of Fludrocortisone can be decreased when it is combined with Phenytoin.	#B32020	0.0982494888570342	1
Lorazepam	Clozapine	0.298	-2.042	Major	25 (9/16)	The risk or severity of adverse effects can be increased when Lorazepam is combined with Clozapine.	#ACCCE3	2.45623722142586	0.163823229537217
Fluoxetine	Clarithromycin	0.241	2.938	Moderate	140 (108/32)	Clarithromycin may increase the QTc-prolonging activities of Fluoxetine.	#F2ACAC	13.7549284399848	1
Moclobemide	Clomipramine	0.5	Inf	None	1 (1/0)	Moclobemide may increase the serotonergic activities of Clomipramine.	#B32020	0.0982494888570342	1
Trimethoprim	Rifampicin	0.493	-1.867	Moderate	21 (8/13)	The metabolism of Trimethoprim can be increased when combined with Rifampicin.	#AECDE3	2.06323926599772	0.000492080961934338
Clonidine	Bisoprolol	0.056	Inf	Major	1 (1/0)	Clonidine may increase the atrioventricular blocking (AV block) activities of Bisoprolol.	#B32020	0.0982494888570342	1
Omeprazole	Halazepam	0.301	2.031	Moderate	50 (35/15)		#F5B4B4	4.91247444285171	1
Acitretin	Methotrexate	0.331	-3.447	Major	4 (1/3)	Acitretin may increase the hepatotoxic activities of Methotrexate.	#A0C3DD	0.392997955428137	0.664779933118548
Sertraline	Clarithromycin	0.172	1.683	Moderate	132 (87/45)	The metabolism of Sertraline can be decreased when combined with Clarithromycin.	#F7B7B7	12.9689325291285	1
Diazepam	Itraconazole	0.425	1.915	Moderate	208 (143/65)	The metabolism of Diazepam can be decreased when combined with Itraconazole.	#F6B6B6	20.4358936822631	1
Fluoxetine	Carbamazepine	0.313	-1.292	Moderate	51 (24/27)	The metabolism of Carbamazepine can be decreased when combined with Fluoxetine.	#B2D0E5	5.01072393170875	1
Clozapine	Lamotrigine	0.218	1.741	Moderate	3 (2/1)	The risk or severity of adverse effects can be increased when Clozapine is combined with Lamotrigine.	#F7B7B7	0.294748466571103	1
Ethinylestradiol	Cloxacillin	0.197	121.858	Moderate	141 (140/1)		#B32020	13.8531779288418	1
Methotrexate	Diclofenac	0.306	1.411	Major	97 (60/37)	The serum concentration of Methotrexate can be increased when it is combined with Diclofenac.	#F7B9B9	9.53020041913232	1
Venlafaxine	Almotriptan	0.228	17.408	Major	21 (20/1)	The risk or severity of adverse effects can be increased when Venlafaxine is combined with Almotriptan.	#BA3131	2.06323926599772	1
Phenytoin	Diazepam	0.319	-2.237	Moderate	56 (19/37)	The serum concentration of Phenytoin can be increased when it is combined with Diazepam.	#ABCBE2	5.50197137599392	1
Propafenone	Acenocoumarol	0.394	-3.447	None	4 (1/3)	The serum concentration of Acenocoumarol can be increased when it is combined with Propafenone.	#A0C3DD	0.392997955428137	0.0108685402154213
Duloxetine	Ciprofloxacin	0.204	2.363	Major	78 (57/21)		#F4B1B1	7.66346013084867	1
Cyclosporine	Modafinil	0.167	Inf	Moderate	1 (1/0)	The serum concentration of Cyclosporine can be decreased when it is combined with Modafinil.	#B32020	0.0982494888570342	1
Clonidine	Clomipramine	0.409	-4.596	Major	5 (1/4)	Clomipramine may decrease the antihypertensive activities of Clonidine.	#97BCD9	0.491247444285171	0.000546871220196814
Atomoxetine	Fluoxetine	0.268	1.451	Major	8 (5/3)	The serum concentration of Atomoxetine can be increased when it is combined with Fluoxetine.	#F7B9B9	0.785995910856274	1
Fluoxetine	Sumatriptan	0.298	8.487	Major	43 (39/4)	The risk or severity of adverse effects can be increased when Fluoxetine is combined with Sumatriptan.	#DC7D7D	4.22472802085247	1
Levothyroxine	Acenocoumarol	0.344	1.335	None	38 (23/15)	Levothyroxine may increase the anticoagulant activities of Acenocoumarol.	#F8BABA	3.7334805765673	1
Fluconazole	Amitriptyline	0.338	11.46	Moderate	85 (79/6)	Amitriptyline may increase the QTc-prolonging activities of Fluconazole.	#D16363	8.35120655284791	1
Verapamil	Lithium cation	0.326	-5.744	Moderate	12 (2/10)	Verapamil may increase the neurotoxic activities of Lithium.	#8EB5D5	1.17899386628441	9.68607488445741e-09
Clozapine	Diazepam	0.261	-3.093	Major	48 (13/35)	The risk or severity of adverse effects can be increased when Diazepam is combined with Clozapine.	#A3C5DF	4.71597546513764	0.174885394769021
Cholestyramine	Ursodeoxycholic acid	0.468	-2.298	None	9 (3/6)	The serum concentration of Ursodeoxycholic acid can be decreased when it is combined with Cholestyramine.	#A9C9E1	0.884245399713308	4.28531247917132e-06
Almotriptan	Sertraline	0.341	20.89	Major	25 (24/1)	The risk or severity of adverse effects can be increased when Almotriptan is combined with Sertraline.	#B32020	2.45623722142586	1
Cyclosporine	Simvastatin	0.299	-1.34	Major	13 (6/7)	The serum concentration of Simvastatin can be increased when it is combined with Cyclosporine.	#B2D0E5	1.27724335514144	1
Pentoxifylline	Acenocoumarol	0.366	3.482	None	5 (4/1)	Pentoxifylline may increase the anticoagulant activities of Acenocoumarol.	#F0A7A7	0.491247444285171	1
Glyburide	Carvedilol	1	Inf	Moderate	1 (1/0)	Carvedilol may increase the hypoglycemic activities of Glyburide.	#B32020	0.0982494888570342	1
Fentanyl	Rifampicin	0.266	-1.149	Major	6 (3/3)	The serum concentration of Fentanyl can be decreased when it is combined with Rifampicin.	#B4D1E6	0.589496933142205	0.562484830014452
Dihydroergotamine	Rizatriptan	0.551	4.787	Major	13 (11/2)	Dihydroergotamine may increase the vasoconstricting activities of Rizatriptan.	#EB9C9C	1.27724335514144	1
Phenytoin	Theophylline	0.5	Inf	Moderate	1 (1/0)	The serum concentration of Theophylline can be decreased when it is combined with Phenytoin.	#B32020	0.0982494888570342	1
Citalopram	Sumatriptan	0.235	4.787	Major	52 (44/8)	The risk or severity of adverse effects can be increased when Citalopram is combined with Sumatriptan.	#EB9C9C	5.10897342056578	1
Fenofibrate	Acenocoumarol	0.375	-1.532	None	7 (3/4)	Fenofibrate may increase the anticoagulant activities of Acenocoumarol.	#B1CFE5	0.68774642199924	1
Metoprolol	Dihydroergotamine	0.282	Inf	Moderate	2 (2/0)	Dihydroergotamine may increase the atrioventricular blocking (AV block) activities of Metoprolol.	#B32020	0.196498977714068	1
Citalopram	Almotriptan	0.272	5.745	Major	38 (33/5)	The risk or severity of adverse effects can be increased when Citalopram is combined with Almotriptan.	#E79494	3.7334805765673	1
Paroxetine	Acenocoumarol	0.334	2.176	None	28 (20/8)	Paroxetine may increase the anticoagulant activities of Acenocoumarol.	#F5B2B2	2.75098568799696	1
Lidocaine	Carvedilol	0.25	Inf	Moderate	2 (2/0)	The serum concentration of Lidocaine can be increased when it is combined with Carvedilol.	#B32020	0.196498977714068	1
Fluoxetine	Ergotamine	0.23	3.337	Major	29 (23/6)	The risk or severity of adverse effects can be increased when Ergotamine is combined with Fluoxetine.	#F0A9A9	2.84923517685399	1
Atenolol	Salbutamol	0.243	1.272	Moderate	64 (38/26)	Atenolol may decrease the bronchodilatory activities of Salbutamol.	#F8BABA	6.28796728685019	1
Carbamazepine	Oxybutynin	0.478	1.306	None	5 (3/2)	The metabolism of Oxybutynin can be increased when combined with Carbamazepine.	#F8BABA	0.491247444285171	1
Warfarin	Phenobarbital	0.704	Inf	Major	1 (1/0)	The metabolism of Warfarin can be increased when combined with Phenobarbital.	#B32020	0.0982494888570342	1
Labetalol	Ibuprofen	0.323	23.719	Moderate	113 (109/4)	Ibuprofen may decrease the antihypertensive activities of Labetalol.	#B32020	11.1021922408449	1
Acetylsalicylic acid	Gliclazide	0.486	-1.97	None	19 (7/12)	Acetylsalicylic acid may increase the hypoglycemic activities of Gliclazide.	#ACCCE3	1.86674028828365	0.0373620855754686
Erythromycin	Levofloxacin	0.747	2.539	Moderate	47 (35/12)	Erythromycin may increase the QTc-prolonging activities of Levofloxacin.	#F3AFAF	4.61772597628061	1
Warfarin	Azathioprine	0.351	1.741	Moderate	3 (2/1)	Azathioprine may decrease the anticoagulant activities of Warfarin.	#F7B7B7	0.294748466571103	1
Rifampicin	Leflunomide	0.236	1.741	Major	3 (2/1)	The serum concentration of the active metabolites of Leflunomide can be increased when Leflunomide is used in combination with Rifampicin.	#F7B7B7	0.294748466571103	1
Indomethacin	Propranolol	0.459	3.133	Moderate	23 (18/5)	Indomethacin may decrease the antihypertensive activities of Propranolol.	#F1ABAB	2.25973824371179	1
Atenolol	Gliclazide	0.155	1.306	None	5 (3/2)	Atenolol may increase the hypoglycemic activities of Gliclazide.	#F8BABA	0.491247444285171	1
Lovastatin	Rifampicin	1	Inf	Major	1 (1/0)	The metabolism of Lovastatin can be increased when combined with Rifampicin.	#B32020	0.0982494888570342	1
Duloxetine	Nortriptyline	0.325	Inf	Major	3 (3/0)	Duloxetine may increase the serotonergic activities of Nortriptyline.	#B32020	0.294748466571103	1
Fluvoxamine	Duloxetine	0.176	-1.641	Major	17 (7/10)	The serum concentration of Duloxetine can be increased when it is combined with Fluvoxamine.	#AFCEE4	1.67024131056958	0.057343614118406
Fluoxetine	Doxepin	0.421	2.611	Major	4 (3/1)	The risk or severity of adverse effects can be increased when Fluoxetine is combined with Doxepin.	#F3AFAF	0.392997955428137	1
Rifampicin	Amiodarone	0.5	Inf	Major	1 (1/0)	The serum concentration of Amiodarone can be decreased when it is combined with Rifampicin.	#B32020	0.0982494888570342	1
Citalopram	Oxycodone	0.295	1.741	Moderate	15 (10/5)	The metabolism of Oxycodone can be decreased when combined with Citalopram.	#F7B7B7	1.47374233285551	1
Fluvoxamine	Clozapine	0.464	-6.893	Moderate	7 (1/6)	The serum concentration of Clozapine can be increased when it is combined with Fluvoxamine.	#85AED1	0.68774642199924	3.73812897007767e-05
Salbutamol	Clomipramine	0.181	-1.451	Moderate	86 (38/48)	The risk or severity of adverse effects can be increased when Clomipramine is combined with Salbutamol.	#B1CFE5	8.44945604170494	1
Eletriptan	Venlafaxine	0.246	7.834	Major	10 (9/1)	The serum concentration of Eletriptan can be increased when it is combined with Venlafaxine.	#DF8383	0.982494888570342	1
Eletriptan	Sertraline	0.225	9.575	Major	12 (11/1)	The risk or severity of adverse effects can be increased when Eletriptan is combined with Sertraline.	#D87373	1.17899386628441	1
Ethinylestradiol	Etoricoxib	0.214	Inf	None	47 (47/0)	Etoricoxib may increase the thrombogenic activities of Ethinyl Estradiol.	#B32020	4.61772597628061	1
Atenolol	Verapamil	0.341	-1.723	Major	5 (2/3)	Verapamil may increase the hypotensive activities of Atenolol.	#AFCEE4	0.491247444285171	1
Atomoxetine	Paroxetine	0.228	1.451	Major	8 (5/3)	The serum concentration of Atomoxetine can be increased when it is combined with Paroxetine.	#F7B9B9	0.785995910856274	1
Atenolol	Diltiazem	0.284	-2.298	Major	6 (2/4)	Diltiazem may increase the hypotensive activities of Atenolol.	#A9C9E1	0.589496933142205	0.0642759474603452
Atenolol	Glyburide	1	Inf	Moderate	2 (2/0)	Atenolol may increase the hypoglycemic activities of Glyburide.	#B32020	0.196498977714068	1
Methylprednisolone	Clarithromycin	0.77	1.291	Major	72 (43/29)	The serum concentration of Methylprednisolone can be increased when it is combined with Clarithromycin.	#F8BABA	7.07396319770646	1
Erythromycin	Alprazolam	0.219	1.596	Moderate	102 (66/36)	The serum concentration of Alprazolam can be increased when it is combined with Erythromycin.	#F7B7B7	10.0214478634175	1
Phenytoin	Gabapentin	0.395	-1.723	Moderate	10 (4/6)	The risk or severity of adverse effects can be increased when Gabapentin is combined with Phenytoin.	#AFCEE4	0.982494888570342	1
Selegiline	Escitalopram	0.333	Inf	Major	1 (1/0)	The risk or severity of adverse effects can be increased when Escitalopram is combined with Selegiline.	#B32020	0.0982494888570342	1
Pravastatin	Gemfibrozil	0.484	-5.744	Major	12 (2/10)	The risk or severity of rhabdomyolysis. myoglobinuria. and elevated creatine kinase (CPK) can be increased when Gemfibrozil is combined with Pravastatin.	#8EB5D5	1.17899386628441	0.00559316099610411
Eletriptan	Fluoxetine	0.228	Inf	Major	13 (13/0)	The metabolism of Eletriptan can be decreased when combined with Fluoxetine.	#B32020	1.27724335514144	1
Fludrocortisone	Phenobarbital	0.209	Inf	Moderate	1 (1/0)	The serum concentration of Fludrocortisone can be decreased when it is combined with Phenobarbital.	#B32020	0.0982494888570342	1
Fluoxetine	Acenocoumarol	0.28	2.437	None	19 (14/5)	The metabolism of Acenocoumarol can be decreased when combined with Fluoxetine.	#F4B1B1	1.86674028828365	1
Diltiazem	Atorvastatin	0.571	-10.34	Moderate	20 (2/18)	The serum concentration of Diltiazem can be increased when it is combined with Atorvastatin.	#6898C5	1.96498977714068	1.30819434063774e-17
Phenytoin	Hydrocortisone	0.229	3.482	Moderate	5 (4/1)	The serum concentration of Hydrocortisone can be decreased when it is combined with Phenytoin.	#F0A7A7	0.491247444285171	1
Bisoprolol	Verapamil	0.309	-2.298	Major	6 (2/4)	The metabolism of Bisoprolol can be decreased when combined with Verapamil.	#A9C9E1	0.589496933142205	1
Propranolol	Salbutamol	0.246	1.662	Major	96 (63/33)		#F7B7B7	9.43195093027528	1
Acetylsalicylic acid	Dexamethasone	0.347	4.062	Moderate	17 (14/3)	The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Dexamethasone.	#EDA3A3	1.67024131056958	1
Erythromycin	Diazepam	0.332	1.806	Moderate	123 (83/40)	The metabolism of Diazepam can be decreased when combined with Erythromycin.	#F6B6B6	12.0846871294152	1
Minocycline	Amoxicillin	0.385	1.572	Moderate	174 (112/62)	The therapeutic efficacy of Amoxicillin can be decreased when used in combination with Minocycline.	#F7B7B7	17.095411061124	1
Phenytoin	Topiramate	0.402	-5.17	Moderate	22 (4/18)	The serum concentration of Phenytoin can be increased when it is combined with Topiramate.	#93B8D7	2.16148875485475	3.07819281997201e-08
Phenytoin	Midazolam	0.133	Inf	Moderate	1 (1/0)	The serum concentration of Phenytoin can be increased when it is combined with Midazolam.	#B32020	0.0982494888570342	1
Simvastatin	Clarithromycin	0.255	-1.465	Major	91 (40/51)	The serum concentration of Simvastatin can be increased when it is combined with Clarithromycin.	#B1CFE5	8.94070348599011	1
Oxycodone	Escitalopram	0.224	1.015	Moderate	13 (7/6)	Oxycodone may increase the serotonergic activities of Escitalopram.	#F9BCBC	1.27724335514144	1
Labetalol	Gliclazide	0.228	Inf	None	3 (3/0)	Labetalol may increase the hypoglycemic activities of Gliclazide.	#B32020	0.294748466571103	1
Naproxen	Lithium cation	0.15	1.644	Major	52 (34/18)	The serum concentration of Lithium can be increased when it is combined with Naproxen.	#F7B7B7	5.10897342056578	1
Estradiol	Phenobarbital	0.253	Inf	Moderate	8 (8/0)	The metabolism of Estradiol can be increased when combined with Phenobarbital.	#B32020	0.785995910856274	1
Fluoxetine	Selegiline	0.4	Inf	Major	1 (1/0)	The risk or severity of adverse effects can be increased when Fluoxetine is combined with Selegiline.	#B32020	0.0982494888570342	1
Trimethoprim	Methotrexate	0.254	1.741	Major	12 (8/4)	The risk or severity of adverse effects can be increased when Trimethoprim is combined with Methotrexate.	#F7B7B7	1.17899386628441	1
Prednisone	Rifampicin	0.395	-1.088	Moderate	37 (19/18)	The serum concentration of Prednisone can be decreased when it is combined with Rifampicin.	#B4D1E6	3.63523108771027	1
Chlorpromazine	Propranolol	0.368	1.306	Moderate	5 (3/2)	The metabolism of Propranolol can be decreased when combined with Chlorpromazine.	#F8BABA	0.491247444285171	1
Eletriptan	Escitalopram	0.19	9.575	Major	12 (11/1)	The risk or severity of adverse effects can be increased when Eletriptan is combined with Escitalopram.	#D87373	1.17899386628441	1
Warfarin	Acetylsalicylic acid	0.233	-2.011	Major	11 (4/7)	Acetylsalicylic acid may increase the anticoagulant activities of Warfarin.	#ACCCE3	1.08074437742738	0.0641790786857416
Oxycodone	Sertraline	0.25	1.741	Moderate	9 (6/3)	The metabolism of Oxycodone can be decreased when combined with Sertraline.	#F7B7B7	0.884245399713308	1
Bisoprolol	Insulin aspart	0.163	-1.292	Moderate	17 (8/9)		#B2D0E5	1.67024131056958	1
Methylphenidate	Carbamazepine	0.261	-1.436	None	9 (4/5)		#B1CFE5	0.884245399713308	1
Epinephrine	Doxepin	0.034	Inf	Major	1 (1/0)	Doxepin may decrease the antihypertensive activities of Epinephrine.	#B32020	0.0982494888570342	1
Itraconazole	Budesonide	0.454	-1.002	Major	176 (94/82)	The serum concentration of Budesonide can be increased when it is combined with Itraconazole.	#B4D1E6	17.291910038838	1
Diclofenac	Lithium cation	0.095	-1.014	Moderate	64 (34/30)	The serum concentration of Lithium can be increased when it is combined with Diclofenac.	#B4D1E6	6.28796728685019	1
Clozapine	Fluoxetine	0.522	-3.734	Moderate	17 (4/13)	The serum concentration of Clozapine can be increased when it is combined with Fluoxetine.	#9FC1DD	1.67024131056958	0.00210911452373235
Ethinylestradiol	Minocycline	0.248	Inf	Moderate	41 (41/0)		#B32020	4.0282290431384	1
Fluoxetine	Almotriptan	0.193	6.093	Major	24 (21/3)	The metabolism of Almotriptan can be decreased when combined with Fluoxetine.	#E69191	2.35798773256882	1
Valproic acid	Nimodipine	0.322	1.741	Minor	3 (2/1)		#F7B7B7	0.294748466571103	1
Hydrochlorothiazide	Lithium cation	0.23	1.306	Major	10 (6/4)	Hydrochlorothiazide may decrease the excretion rate of Lithium which could result in a higher serum level.	#F8BABA	0.982494888570342	1
Erythromycin	Methylprednisolone	0.739	1.345	Moderate	28 (17/11)	The metabolism of Methylprednisolone can be decreased when combined with Erythromycin.	#F8BABA	2.75098568799696	1
Zolmitriptan	Dihydroergotamine	0.578	3.482	Major	10 (8/2)	Dihydroergotamine may increase the vasoconstricting activities of Zolmitriptan.	#F0A7A7	0.982494888570342	1
Enalapril	Drospirenone	0.263	Inf	Moderate	26 (26/0)	Enalapril may increase the hyperkalemic activities of Drospirenone.	#B32020	2.55448671028289	1
Methylprednisolone	Phenobarbital	0.165	3.482	Moderate	5 (4/1)	The serum concentration of Methylprednisolone can be decreased when it is combined with Phenobarbital.	#F0A7A7	0.491247444285171	1
Erythromycin	Fluoxetine	0.207	2.785	Moderate	42 (32/10)	The metabolism of Fluoxetine can be decreased when combined with Erythromycin.	#F2AEAE	4.12647853199544	1
Indomethacin	Alendronic acid	0.403	-1.436	Moderate	9 (4/5)	The risk or severity of adverse effects can be increased when Indomethacin is combined with Alendronic acid.	#B1CFE5	0.884245399713308	1
Levothyroxine	Cholestyramine	0.153	2.611	Moderate	16 (12/4)	The serum concentration of Levothyroxine can be decreased when it is combined with Cholestyramine.	#F3AFAF	1.57199182171255	1
Frovatriptan	Escitalopram	0.25	Inf	Major	8 (8/0)	The risk or severity of adverse effects can be increased when Frovatriptan is combined with Escitalopram.	#B32020	0.785995910856274	1
Methotrexate	Cholestyramine	0.238	-1.532	None	7 (3/4)	Cholestyramine can cause a decrease in the absorption of Methotrexate resulting in a reduced serum concentration and potentially a decrease in efficacy.	#B1CFE5	0.68774642199924	0.364042559705265
Ergotamine	Nadolol	0.435	1.741	Moderate	6 (4/2)	Ergotamine may increase the atrioventricular blocking (AV block) activities of Nadolol.	#F7B7B7	0.589496933142205	1
Methotrexate	Sulfamethoxazole	0.269	1.523	Moderate	11 (7/4)	The risk or severity of adverse effects can be increased when Sulfamethoxazole is combined with Methotrexate.	#F7B9B9	1.08074437742738	1
Torasemide	Ibuprofen	0.291	1.291	Moderate	72 (43/29)	The therapeutic efficacy of Torasemide can be decreased when used in combination with Ibuprofen.	#F8BABA	7.07396319770646	1
Dihydroergotamine	Fluoxetine	0.302	3.772	Major	16 (13/3)	The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Fluoxetine.	#EFA6A6	1.57199182171255	1
Cyclosporine	Ciprofloxacin	0.214	-1.723	Moderate	30 (12/18)		#AFCEE4	2.94748466571103	1
Piroxicam	Methotrexate	0.194	1.741	Major	3 (2/1)	The serum concentration of Methotrexate can be increased when it is combined with Piroxicam.	#F7B7B7	0.294748466571103	1
Warfarin	Ranitidine	0.202	5.222	Moderate	7 (6/1)	The serum concentration of Warfarin can be increased when it is combined with Ranitidine.	#E99999	0.68774642199924	1
Cyclosporine	Chloroquine	0.559	-1.149	Moderate	2 (1/1)	Chloroquine may increase the nephrotoxic activities of Cyclosporine.	#B4D1E6	0.196498977714068	1
Citalopram	Eletriptan	0.301	11.315	Major	14 (13/1)	The risk or severity of adverse effects can be increased when Citalopram is combined with Eletriptan.	#D26565	1.37549284399848	1
Fluoxetine	Trimipramine	0.632	Inf	Major	1 (1/0)	The risk or severity of adverse effects can be increased when Fluoxetine is combined with Trimipramine.	#B32020	0.0982494888570342	1
Fluconazole	Flurazepam	0.165	6.963	None	9 (8/1)	The metabolism of Flurazepam can be decreased when combined with Fluconazole.	#E28989	0.884245399713308	1
Clozapine	Sertraline	0.322	-3.064	Major	11 (3/8)	The serum concentration of Clozapine can be increased when it is combined with Sertraline.	#A3C5DF	1.08074437742738	0.59928844109889
Furosemide	Gentamicin	0.5	Inf	Major	1 (1/0)	The serum concentration of Gentamicin can be increased when it is combined with Furosemide.	#B32020	0.0982494888570342	1
Eletriptan	Paroxetine	0.278	2.829	Major	17 (13/4)	The metabolism of Eletriptan can be decreased when combined with Paroxetine.	#F2AEAE	1.67024131056958	1
Sumatriptan	Escitalopram	0.342	2.86	Major	30 (23/7)	The risk or severity of adverse effects can be increased when Sumatriptan is combined with Escitalopram.	#F2ACAC	2.94748466571103	1
Fluconazole	Simvastatin	0.229	1.097	Major	52 (29/23)	The serum concentration of Simvastatin can be increased when it is combined with Fluconazole.	#F9BCBC	5.10897342056578	1
Haloperidol	Propranolol	0.323	-5.285	Moderate	28 (5/23)	The metabolism of Propranolol can be decreased when combined with Haloperidol.	#91B7D7	2.75098568799696	9.16281377725468e-07
Lamotrigine	Ethinylestradiol	0.228	Inf	Moderate	30 (30/0)	The serum concentration of Lamotrigine can be decreased when it is combined with Ethinyl Estradiol.	#B32020	2.94748466571103	1
Tacrolimus	Nifedipine	0.349	-6.702	Moderate	41 (6/35)	The serum concentration of Tacrolimus can be increased when it is combined with Nifedipine.	#86AFD2	4.0282290431384	4.6802662083739e-20
Warfarin	Ibuprofen	0.232	1.015	Major	39 (21/18)	Ibuprofen may increase the anticoagulant activities of Warfarin.	#F9BCBC	3.83173006542433	1
Phenytoin	Alprazolam	0.268	-1.787	Moderate	23 (9/14)	The serum concentration of Phenytoin can be increased when it is combined with Alprazolam.	#AECDE3	2.25973824371179	1
Propranolol	Primidone	0.42	-3.447	Moderate	4 (1/3)	The metabolism of Propranolol can be increased when combined with Primidone.	#A0C3DD	0.392997955428137	0.391165394178273
Carvedilol	Insulin glulisine	0.313	-2.298	Moderate	3 (1/2)		#A9C9E1	0.294748466571103	1
Citalopram	Moclobemide	0.171	Inf	None	2 (2/0)	The serum concentration of Citalopram can be increased when it is combined with Moclobemide.	#B32020	0.196498977714068	1
Azithromycin	Acenocoumarol	0.114	1.126	None	39 (22/17)	The metabolism of Acenocoumarol can be decreased when combined with Azithromycin.	#F9BCBC	3.83173006542433	1
Cyclosporine	Carvedilol	0.323	-4.596	Moderate	5 (1/4)	The serum concentration of Cyclosporine can be increased when it is combined with Carvedilol.	#97BCD9	0.491247444285171	0.0353521467614802
Citalopram	Acenocoumarol	0.314	-1.856	None	34 (13/21)	The metabolism of Acenocoumarol can be decreased when combined with Citalopram.	#AECDE3	3.34048262113916	1
Pantoprazole	Itraconazole	0.502	2.86	Moderate	30 (23/7)	The serum concentration of Itraconazole can be decreased when it is combined with Pantoprazole.	#F2ACAC	2.94748466571103	1
Cyclosporine	Mefenamic acid	0.113	Inf	Moderate	1 (1/0)	Mefenamic acid may increase the nephrotoxic activities of Cyclosporine.	#B32020	0.0982494888570342	1
Ciprofloxacin	Acenocoumarol	0.158	-1.939	None	43 (16/27)		#ACCCE3	4.22472802085247	1
Prednisone	Warfarin	0.251	-1.149	Moderate	14 (7/7)	Prednisone may increase the anticoagulant activities of Warfarin.	#B4D1E6	1.37549284399848	1
Levofloxacin	Methotrimeprazine	0.131	-1.58	Moderate	19 (8/11)	Methotrimeprazine may increase the QTc-prolonging activities of Levofloxacin.	#AFCEE4	1.86674028828365	1
Fluconazole	Tacrolimus	0.419	2.285	Major	29 (21/8)	The serum concentration of Tacrolimus can be increased when it is combined with Fluconazole.	#F5B2B2	2.84923517685399	1
Fluoxetine	Oxycodone	0.151	1.741	Moderate	9 (6/3)	The metabolism of Oxycodone can be decreased when combined with Fluoxetine.	#F7B7B7	0.884245399713308	1
Dihydroergotamine	Naratriptan	0.5	Inf	Major	1 (1/0)	Dihydroergotamine may increase the vasoconstricting activities of Naratriptan.	#B32020	0.0982494888570342	1
Propranolol	Phenobarbital	0.424	-2.298	Moderate	12 (4/8)	The metabolism of Propranolol can be increased when combined with Phenobarbital.	#A9C9E1	1.17899386628441	0.455844694894189
Amitriptyline	Terbutaline	0.176	6.31	Moderate	33 (29/4)	The risk or severity of adverse effects can be increased when Amitriptyline is combined with Terbutaline.	#E59090	3.24223313228213	1
Dihydroergotamine	Propranolol	0.305	3.046	Moderate	9 (7/2)	Dihydroergotamine may increase the atrioventricular blocking (AV block) activities of Propranolol.	#F1ABAB	0.884245399713308	1
Dihydroergotamine	Sumatriptan	0.435	5.222	Major	7 (6/1)	Dihydroergotamine may increase the vasoconstricting activities of Sumatriptan.	#E99999	0.68774642199924	1
Cyclosporine	Ibuprofen	0.21	-1.149	Moderate	62 (31/31)	Ibuprofen may increase the nephrotoxic activities of Cyclosporine.	#B4D1E6	6.09146830913612	1
Cyclosporine	Azithromycin	0.181	1.741	Moderate	21 (14/7)	The metabolism of Cyclosporine can be decreased when combined with Azithromycin.	#F7B7B7	2.06323926599772	1
Medroxyprogesterone acetate	Primidone	0.038	Inf	Moderate	1 (1/0)	The therapeutic efficacy of Medroxyprogesterone acetate can be decreased when used in combination with Primidone.	#B32020	0.0982494888570342	1
Warfarin	Pentoxifylline	0.394	Inf	Moderate	1 (1/0)	Pentoxifylline may increase the anticoagulant activities of Warfarin.	#B32020	0.0982494888570342	1
Cyclosporine	Metoclopramide	0.142	1.064	Moderate	20 (11/9)	Metoclopramide can cause an increase in the absorption of Cyclosporine resulting in an increased serum concentration and potentially a worsening of adverse effects.	#F9BCBC	1.96498977714068	1
Clozapine	Carbamazepine	0.203	-1.149	Major	2 (1/1)	Carbamazepine may increase the myelosuppressive activities of Clozapine.	#B4D1E6	0.196498977714068	1
Cyclosporine	Indomethacin	0.554	-1.532	Moderate	7 (3/4)	Indomethacin may increase the nephrotoxic activities of Cyclosporine.	#B1CFE5	0.68774642199924	1
Metoprolol	Ibuprofen	0.294	2.901	Moderate	26 (20/6)	Ibuprofen may decrease the antihypertensive activities of Metoprolol.	#F2ACAC	2.55448671028289	1
Tetracycline	Ethinylestradiol	0.172	Inf	None	17 (17/0)		#B32020	1.67024131056958	1
Amitriptyline	Pseudoephedrine	0.369	8.994	None	34 (31/3)	Amitriptyline may decrease the antihypertensive activities of Pseudoephedrine.	#DA7878	3.34048262113916	1
Phenytoin	Trimethoprim	0.289	-1.723	Moderate	5 (2/3)	The serum concentration of Phenytoin can be increased when it is combined with Trimethoprim.	#AFCEE4	0.491247444285171	1
Rifampicin	Dexamethasone	0.391	2.611	Moderate	4 (3/1)	The serum concentration of Dexamethasone can be decreased when it is combined with Rifampicin.	#F3AFAF	0.392997955428137	1
Phenytoin	Rifampicin	0.3	Inf	Major	1 (1/0)	The serum concentration of Phenytoin can be decreased when it is combined with Rifampicin.	#B32020	0.0982494888570342	1
Gentamicin	Cefuroxime	0.583	2.611	Moderate	4 (3/1)		#F3AFAF	0.392997955428137	1
Cyclosporine	Naproxen	0.189	2.611	Moderate	20 (15/5)	Naproxen may increase the nephrotoxic activities of Cyclosporine.	#F3AFAF	1.96498977714068	1
Eletriptan	Ergotamine	0.234	Inf	Major	3 (3/0)	Ergotamine may increase the vasoconstricting activities of Eletriptan.	#B32020	0.294748466571103	1
Carbamazepine	Acenocoumarol	0.23	-3.447	None	12 (3/9)	The serum concentration of Acenocoumarol can be decreased when it is combined with Carbamazepine.	#A0C3DD	1.17899386628441	0.29450444296984
Fluvoxamine	Acenocoumarol	0.694	1.741	None	3 (2/1)	The metabolism of Acenocoumarol can be decreased when combined with Fluvoxamine.	#F7B7B7	0.294748466571103	1
Ciprofloxacin	Methotrexate	0.168	1.654	Moderate	29 (19/10)	The serum concentration of Methotrexate can be increased when it is combined with Ciprofloxacin.	#F7B7B7	2.84923517685399	1
Tacrolimus	Felodipine	0.111	Inf	Moderate	1 (1/0)	The serum concentration of Tacrolimus can be increased when it is combined with Felodipine.	#B32020	0.0982494888570342	1
Fluconazole	Carbamazepine	0.139	2.176	Moderate	21 (15/6)	The serum concentration of Carbamazepine can be increased when it is combined with Fluconazole.	#F5B2B2	2.06323926599772	1
Acetylsalicylic acid	Glyburide	0.721	-4.978	Moderate	16 (3/13)	Acetylsalicylic acid may increase the hypoglycemic activities of Glyburide.	#94B9D8	1.57199182171255	0.000390920743695297
Phenytoin	Acenocoumarol	0.248	-2.298	None	3 (1/2)	Phenytoin may increase the anticoagulant activities of Acenocoumarol.	#A9C9E1	0.294748466571103	1
Cyclosporine	Nifedipine	0.359	-1.149	Moderate	4 (2/2)	The metabolism of Nifedipine can be decreased when combined with Cyclosporine.	#B4D1E6	0.392997955428137	1
Ciprofloxacin	Sevelamer	0.118	-2.011	Moderate	11 (4/7)		#ACCCE3	1.08074437742738	1
Levothyroxine	Warfarin	0.205	4.352	Moderate	6 (5/1)	Levothyroxine may increase the anticoagulant activities of Warfarin.	#EC9F9F	0.589496933142205	1
Atenolol	Salmeterol	0.142	1.741	Moderate	12 (8/4)	Atenolol may decrease the bronchodilatory activities of Salmeterol.	#F7B7B7	1.17899386628441	1
Erythromycin	Moxifloxacin	0.727	1.257	Major	22 (13/9)	Erythromycin may increase the QTc-prolonging activities of Moxifloxacin.	#F8BABA	2.16148875485475	1
Pimozide	Itraconazole	0.105	Inf	Major	2 (2/0)	The serum concentration of Pimozide can be increased when it is combined with Itraconazole.	#B32020	0.196498977714068	1
Salbutamol	Carvedilol	0.149	-1.404	Major	20 (9/11)	Carvedilol may decrease the vasoconstricting activities of Salbutamol.	#B1CFE5	1.96498977714068	1
Carbamazepine	Metronidazole	0.219	1.915	Moderate	16 (11/5)	The metabolism of Metronidazole can be increased when combined with Carbamazepine.	#F6B6B6	1.57199182171255	1
Trazodone	Acenocoumarol	0.303	-1.149	None	8 (4/4)		#B4D1E6	0.785995910856274	1
Gemfibrozil	Acenocoumarol	0.331	-4.596	None	10 (2/8)	The metabolism of Acenocoumarol can be decreased when combined with Gemfibrozil.	#97BCD9	0.982494888570342	1
Fluoxetine	Carvedilol	0.3	-1.608	Moderate	12 (5/7)	The metabolism of Carvedilol can be decreased when combined with Fluoxetine.	#AFCEE4	1.17899386628441	1
Phenytoin	Estradiol	0.315	Inf	Moderate	4 (4/0)	The therapeutic efficacy of Estradiol can be decreased when used in combination with Phenytoin.	#B32020	0.392997955428137	1
Pseudoephedrine	Clomipramine	0.144	1.064	None	20 (11/9)	Clomipramine may decrease the antihypertensive activities of Pseudoephedrine.	#F9BCBC	1.96498977714068	1
Erythromycin	Lincomycin	0.667	1.741	Moderate	3 (2/1)	The therapeutic efficacy of Erythromycin can be decreased when used in combination with Lincomycin.	#F7B7B7	0.294748466571103	1
Rifabutin	Itraconazole	0.341	-1.149	None	2 (1/1)	The serum concentration of Itraconazole can be decreased when it is combined with Rifabutin.	#B4D1E6	0.196498977714068	1
Sumatriptan	Lithium cation	0.261	-2.068	None	14 (5/9)	The risk or severity of adverse effects can be increased when Sumatriptan is combined with Lithium.	#ACCCE3	1.37549284399848	1
Ciprofloxacin	Iron	0.512	6.16	Moderate	105 (92/13)		#E69191	10.3161963299886	1
Naproxen	Acenocoumarol	0.176	1.934	None	29 (20/9)	Naproxen may increase the anticoagulant activities of Acenocoumarol.	#F5B4B4	2.84923517685399	1
Folic acid	Phenobarbital	0.303	1.119	Moderate	16 (9/7)	The serum concentration of Phenobarbital can be decreased when it is combined with Folic Acid.	#F9BCBC	1.57199182171255	1
Betamethasone	Acetylsalicylic acid	0.381	Inf	Moderate	7 (7/0)	The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Betamethasone.	#B32020	0.68774642199924	1
Salbutamol	Doxepin	0.301	1.306	Moderate	5 (3/2)	The risk or severity of adverse effects can be increased when Doxepin is combined with Salbutamol.	#F8BABA	0.491247444285171	1
Fludrocortisone	Acetylsalicylic acid	0.155	Inf	Moderate	3 (3/0)	The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Fludrocortisone.	#B32020	0.294748466571103	1
Bisoprolol	Salbutamol	0.224	-1.587	Moderate	50 (21/29)	Bisoprolol may decrease the bronchodilatory activities of Salbutamol.	#AFCEE4	4.91247444285171	1
Phenytoin	Prednisone	0.19	-1.532	Moderate	14 (6/8)	The serum concentration of Prednisone can be decreased when it is combined with Phenytoin.	#B1CFE5	1.37549284399848	1
Cimetidine	Clonazepam	0.611	-1.149	Moderate	2 (1/1)		#B4D1E6	0.196498977714068	1
Ibuprofen	Carvedilol	0.152	-3.009	Moderate	76 (21/55)	Ibuprofen may decrease the antihypertensive activities of Carvedilol.	#A5C6DF	7.4669611531346	1
Oxcarbazepine	Ethinylestradiol	0.231	Inf	Major	18 (18/0)	The serum concentration of Ethinyl Estradiol can be decreased when it is combined with Oxcarbazepine.	#B32020	1.76849079942662	1
Bisoprolol	Ergotamine	0.305	1.741	Moderate	6 (4/2)	Ergotamine may increase the atrioventricular blocking (AV block) activities of Bisoprolol.	#F7B7B7	0.589496933142205	1
Ranitidine	Acenocoumarol	0.347	1.243	None	17 (10/7)		#F8BABA	1.67024131056958	1
Methimazole	Acenocoumarol	0.202	-1.149	None	6 (3/3)	Methimazole may decrease the anticoagulant activities of Acenocoumarol.	#B4D1E6	0.589496933142205	1
Venlafaxine	Naratriptan	0.56	Inf	Major	2 (2/0)	The risk or severity of adverse effects can be increased when Venlafaxine is combined with Naratriptan.	#B32020	0.196498977714068	1
Prednisolone	Phenobarbital	0.048	Inf	Moderate	1 (1/0)	The serum concentration of Prednisolone can be decreased when it is combined with Phenobarbital.	#B32020	0.0982494888570342	1
Eletriptan	Dihydroergotamine	0.587	Inf	Major	2 (2/0)	The serum concentration of Eletriptan can be increased when it is combined with Dihydroergotamine.	#B32020	0.196498977714068	1
Nortriptyline	Carbamazepine	0.476	-2.298	Moderate	3 (1/2)	The metabolism of Nortriptyline can be increased when combined with Carbamazepine.	#A9C9E1	0.294748466571103	1
Alendronic acid	Naproxen	0.299	2.437	Moderate	19 (14/5)	The risk or severity of adverse effects can be increased when Naproxen is combined with Alendronic acid.	#F4B1B1	1.86674028828365	1
Theophylline	Disulfiram	0.05	Inf	Moderate	1 (1/0)	The serum concentration of Theophylline can be increased when it is combined with Disulfiram.	#B32020	0.0982494888570342	1
Omeprazole	Ketoconazole	0.535	-1.057	Moderate	48 (25/23)	The serum concentration of Ketoconazole can be decreased when it is combined with Omeprazole.	#B4D1E6	4.71597546513764	1
Norfloxacin	Acenocoumarol	0.085	3.192	None	14 (11/3)	Norfloxacin may increase the anticoagulant activities of Acenocoumarol.	#F1ABAB	1.37549284399848	1
Ergotamine	Frovatriptan	0.625	Inf	Major	2 (2/0)	Ergotamine may increase the vasoconstricting activities of Frovatriptan.	#B32020	0.196498977714068	1
Erythromycin	Citalopram	0.162	1.209	Major	43 (25/18)	The metabolism of Citalopram can be decreased when combined with Erythromycin.	#F8BABA	4.22472802085247	1
Ergotamine	Naratriptan	0.333	Inf	Major	1 (1/0)	Ergotamine may increase the vasoconstricting activities of Naratriptan.	#B32020	0.0982494888570342	1
Hydrocortisone	Acenocoumarol	0.371	1.088	None	9 (5/4)		#F9BCBC	0.884245399713308	1
Erythromycin	Cabergoline	0.625	14.797	Major	18 (17/1)	The risk or severity of adverse effects can be increased when Cabergoline is combined with Erythromycin.	#C44747	1.76849079942662	1
Phenytoin	Isoniazid	0.3	Inf	Moderate	1 (1/0)	The serum concentration of Phenytoin can be increased when it is combined with Isoniazid.	#B32020	0.0982494888570342	1
Carbamazepine	Bupropion	0.151	-1.532	Moderate	7 (3/4)	The metabolism of Bupropion can be increased when combined with Carbamazepine.	#B1CFE5	0.68774642199924	1
Indomethacin	Bisoprolol	0.503	-1.149	Moderate	10 (5/5)	Indomethacin may decrease the antihypertensive activities of Bisoprolol.	#B4D1E6	0.982494888570342	1
Phenytoin	Mirtazapine	0.277	-1.723	Moderate	5 (2/3)	Phenytoin may increase the central nervous system depressant (CNS depressant) activities of Mirtazapine.	#AFCEE4	0.491247444285171	1
Glyburide	Glucosamine	0.034	Inf	None	1 (1/0)		#B32020	0.0982494888570342	1
Prednisone	Itraconazole	0.574	1.05	Moderate	75 (41/34)	The serum concentration of Prednisone can be increased when it is combined with Itraconazole.	#F9BCBC	7.36871166427757	1
Diltiazem	Amlodipine	0.321	-6.893	Moderate	7 (1/6)	The metabolism of Amlodipine can be decreased when combined with Diltiazem.	#85AED1	0.68774642199924	0.00629007159905478
Bisoprolol	Insulin detemir	0.217	1.741	Moderate	3 (2/1)		#F7B7B7	0.294748466571103	1
Hydrocortisone	Phenobarbital	0.13	-1.532	Moderate	7 (3/4)	The serum concentration of Hydrocortisone can be decreased when it is combined with Phenobarbital.	#B1CFE5	0.68774642199924	1
Bisoprolol	Terbutaline	0.142	1.393	Moderate	13 (8/5)	Bisoprolol may decrease the bronchodilatory activities of Terbutaline.	#F7B9B9	1.27724335514144	1
Itraconazole	Clarithromycin	0.684	2.089	Moderate	51 (36/15)	The metabolism of Clarithromycin can be decreased when combined with Itraconazole.	#F5B4B4	5.01072393170875	1
Folic acid	Phenytoin	0.432	1.741	Moderate	9 (6/3)	The serum concentration of Phenytoin can be decreased when it is combined with Folic Acid.	#F7B7B7	0.884245399713308	1
Alendronic acid	Ketoprofen	1	Inf	Moderate	1 (1/0)	The risk or severity of adverse effects can be increased when Ketoprofen is combined with Alendronic acid.	#B32020	0.0982494888570342	1
Fluvoxamine	Zolmitriptan	0.127	Inf	Moderate	4 (4/0)	The metabolism of Zolmitriptan can be decreased when combined with Fluvoxamine.	#B32020	0.392997955428137	1
Propranolol	Formoterol	0.27	1.583	Major	31 (20/11)		#F7B7B7	3.04573415456806	1
Warfarin	Hydrocortisone	0.212	1.741	Moderate	3 (2/1)	Hydrocortisone may increase the anticoagulant activities of Warfarin.	#F7B7B7	0.294748466571103	1
Estradiol	Ursodeoxycholic acid	0.175	Inf	None	7 (7/0)	The therapeutic efficacy of Ursodeoxycholic acid can be decreased when used in combination with Estradiol.	#B32020	0.68774642199924	1
Spironolactone	Cholestyramine	0.5	Inf	Moderate	1 (1/0)	The risk or severity of adverse effects can be increased when Cholestyramine is combined with Spironolactone.	#B32020	0.0982494888570342	1
Fluconazole	Fentanyl	0.43	-1.477	Major	16 (7/9)	The serum concentration of Fentanyl can be increased when it is combined with Fluconazole.	#B1CFE5	1.57199182171255	1
Doxycycline	Cloxacillin	0.637	-1.388	Moderate	53 (24/29)	The therapeutic efficacy of Cloxacillin can be decreased when used in combination with Doxycycline.	#B1CFE5	5.20722290942281	1
Diltiazem	Propranolol	0.567	1.741	Major	3 (2/1)	The metabolism of Propranolol can be decreased when combined with Diltiazem.	#F7B7B7	0.294748466571103	1
Levofloxacin	Josamycin	0.697	1.523	None	11 (7/4)		#F7B9B9	1.08074437742738	1
Cyclosporine	Fluoxetine	0.177	4.352	Moderate	6 (5/1)	The metabolism of Fluoxetine can be decreased when combined with Cyclosporine.	#EC9F9F	0.589496933142205	1
Piroxicam	Lithium cation	0.607	Inf	Major	1 (1/0)	The serum concentration of Lithium can be increased when it is combined with Piroxicam.	#B32020	0.0982494888570342	1
Cyclosporine	Fluconazole	0.283	-1.532	Moderate	14 (6/8)	The serum concentration of Cyclosporine can be increased when it is combined with Fluconazole.	#B1CFE5	1.37549284399848	1
Amitriptyline	Moclobemide	0.026	Inf	None	1 (1/0)	The risk or severity of adverse effects can be increased when Amitriptyline is combined with Moclobemide.	#B32020	0.0982494888570342	1
Carbamazepine	Ethinylestradiol	0.107	Inf	Major	18 (18/0)	The therapeutic efficacy of Ethinyl Estradiol can be decreased when used in combination with Carbamazepine.	#B32020	1.76849079942662	1
Prednisone	Phenobarbital	0.112	-1.149	Moderate	14 (7/7)	The serum concentration of Prednisone can be decreased when it is combined with Phenobarbital.	#B4D1E6	1.37549284399848	1
Fluconazole	Atorvastatin	0.206	1.741	Major	18 (12/6)	The serum concentration of Atorvastatin can be increased when it is combined with Fluconazole.	#F7B7B7	1.76849079942662	1
Labetalol	Salbutamol	0.251	Inf	Major	20 (20/0)	Labetalol may decrease the vasoconstricting activities of Salbutamol.	#B32020	1.96498977714068	1
Diclofenac	Alendronic acid	0.235	1.257	Moderate	22 (13/9)	The risk or severity of adverse effects can be increased when Diclofenac is combined with Alendronic acid.	#F8BABA	2.16148875485475	1
Sotalol	Ibuprofen	0.112	-1.149	Moderate	12 (6/6)	Ibuprofen may decrease the antihypertensive activities of Sotalol.	#B4D1E6	1.17899386628441	1
Diltiazem	Carbamazepine	0.115	-1.149	Major	2 (1/1)	The serum concentration of Carbamazepine can be increased when it is combined with Diltiazem.	#B4D1E6	0.196498977714068	1
Clonazepam	Itraconazole	0.275	1.161	None	28 (16/12)	The metabolism of Clonazepam can be decreased when combined with Itraconazole.	#F9BCBC	2.75098568799696	1
Fluoxetine	Warfarin	0.182	1.306	Moderate	5 (3/2)	The metabolism of Warfarin can be decreased when combined with Fluoxetine.	#F8BABA	0.491247444285171	1
Sucralfate	Levothyroxine	0.073	Inf	Minor	10 (10/0)	The serum concentration of Levothyroxine can be decreased when it is combined with Sucralfate.	#B32020	0.982494888570342	1
Metoprolol	Escitalopram	0.593	Inf	Minor	3 (3/0)	The serum concentration of Metoprolol can be increased when it is combined with Escitalopram.	#B32020	0.294748466571103	1
Metronidazole	Phenobarbital	0.036	1.161	Moderate	7 (4/3)	The serum concentration of Metronidazole can be decreased when it is combined with Phenobarbital.	#F9BCBC	0.68774642199924	1
Fluoxetine	Frovatriptan	0.299	Inf	Major	5 (5/0)	The risk or severity of adverse effects can be increased when Fluoxetine is combined with Frovatriptan.	#B32020	0.491247444285171	1
Digoxin	Levothyroxine	0.423	-1.149	Moderate	6 (3/3)		#B4D1E6	0.589496933142205	1
Nabumetone	Acenocoumarol	0.167	Inf	None	1 (1/0)	Nabumetone may increase the anticoagulant activities of Acenocoumarol.	#B32020	0.0982494888570342	1
Bisoprolol	Formoterol	0.196	-2.528	Moderate	32 (10/22)	Bisoprolol may decrease the bronchodilatory activities of Formoterol.	#A8C8E1	3.14398364342509	1
Levofloxacin	Acenocoumarol	0.186	-1.149	None	12 (6/6)	Levofloxacin may increase the anticoagulant activities of Acenocoumarol.	#B4D1E6	1.17899386628441	1
Trospium	Cyclobenzaprine	0.533	Inf	Moderate	2 (2/0)		#B32020	0.196498977714068	1
Metronidazole	Lithium cation	0.053	1.219	Moderate	12 (7/5)		#F8BABA	1.17899386628441	1
Ziprasidone	Ketoconazole	0.225	-1.149	Major	2 (1/1)	The metabolism of Ziprasidone can be decreased when combined with Ketoconazole.	#B4D1E6	0.196498977714068	1
Amitriptyline	Clonidine	0.6	Inf	Major	1 (1/0)	Amitriptyline may decrease the antihypertensive activities of Clonidine.	#B32020	0.0982494888570342	1
Phenytoin	Furosemide	0.368	-4.596	Minor	5 (1/4)	Phenytoin may decrease the diuretic activities of Furosemide.	#97BCD9	0.491247444285171	1
Estradiol	Primidone	0.382	Inf	Moderate	1 (1/0)	The metabolism of Estradiol can be increased when combined with Primidone.	#B32020	0.0982494888570342	1
Digoxin	Alprazolam	0.431	-1.436	Moderate	9 (4/5)		#B1CFE5	0.884245399713308	1
Cyproheptadine	Fluoxetine	0.174	1.741	Moderate	3 (2/1)	The therapeutic efficacy of Fluoxetine can be decreased when used in combination with Cyproheptadine.	#F7B7B7	0.294748466571103	1
Enalapril	Lithium cation	0.235	-2.298	Moderate	12 (4/8)	The serum concentration of Lithium can be increased when it is combined with Enalapril.	#A9C9E1	1.17899386628441	1
Paroxetine	Frovatriptan	0.274	2.611	None	8 (6/2)	The risk or severity of adverse effects can be increased when Paroxetine is combined with Frovatriptan.	#F3AFAF	0.785995910856274	1
Doxycycline	Methotrexate	0.147	3.046	Moderate	9 (7/2)		#F1ABAB	0.884245399713308	1
Pregabalin	Pioglitazone	0.021	Inf	Moderate	1 (1/0)	The risk or severity of heart failure can be increased when Pregabalin is combined with Pioglitazone.	#B32020	0.0982494888570342	1
Hydrocortisone	Acetylsalicylic acid	0.45	1.414	Moderate	21 (13/8)	The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Hydrocortisone.	#F7B9B9	2.06323926599772	1
Trospium	Loratadine	0.689	Inf	None	3 (3/0)		#B32020	0.294748466571103	1
Phenobarbital	Acenocoumarol	0.24	-2.298	None	3 (1/2)	The metabolism of Acenocoumarol can be increased when combined with Phenobarbital.	#A9C9E1	0.294748466571103	1
Paroxetine	Naratriptan	0.653	Inf	Major	3 (3/0)	The risk or severity of adverse effects can be increased when Paroxetine is combined with Naratriptan.	#B32020	0.294748466571103	1
Tacrolimus	Itraconazole	0.701	-2.042	Major	25 (9/16)	The serum concentration of Tacrolimus can be increased when it is combined with Itraconazole.	#ACCCE3	2.45623722142586	1
Indomethacin	Furosemide	0.725	1.741	Moderate	6 (4/2)	The therapeutic efficacy of Furosemide can be decreased when used in combination with Indomethacin.	#F7B7B7	0.589496933142205	1
Erythromycin	Simvastatin	0.242	-1.021	Major	17 (9/8)	The serum concentration of Simvastatin can be increased when it is combined with Erythromycin.	#B4D1E6	1.67024131056958	1
Atenolol	Insulin aspart	0.107	-1.723	Moderate	10 (4/6)		#AFCEE4	0.982494888570342	1
Theophylline	Clarithromycin	1	-2.068	Moderate	14 (5/9)	The metabolism of Theophylline can be decreased when combined with Clarithromycin.	#ACCCE3	1.37549284399848	1
Minocycline	Cloxacillin	0.64	-1.053	Moderate	23 (12/11)	The therapeutic efficacy of Cloxacillin can be decreased when used in combination with Minocycline.	#B4D1E6	2.25973824371179	1
Simvastatin	Amiodarone	0.386	-3.447	Major	4 (1/3)	The serum concentration of Simvastatin can be increased when it is combined with Amiodarone.	#A0C3DD	0.392997955428137	1
Colestipol	Levothyroxine	0.239	1.741	Moderate	3 (2/1)	The serum concentration of Levothyroxine can be decreased when it is combined with Colestipol.	#F7B7B7	0.294748466571103	1
Fluconazole	Halazepam	0.3	Inf	None	5 (5/0)		#B32020	0.491247444285171	1
Alprazolam	Ketoconazole	0.341	1.306	Major	20 (12/8)	The serum concentration of Alprazolam can be increased when it is combined with Ketoconazole.	#F8BABA	1.96498977714068	1
Lamotrigine	Norethisterone	0.542	Inf	Moderate	3 (3/0)		#B32020	0.294748466571103	1
Fluvoxamine	Frovatriptan	0.083	Inf	Major	1 (1/0)	The metabolism of Frovatriptan can be decreased when combined with Fluvoxamine.	#B32020	0.0982494888570342	1
Clarithromycin	Acenocoumarol	0.167	1.306	None	15 (9/6)	The metabolism of Acenocoumarol can be decreased when combined with Clarithromycin.	#F8BABA	1.47374233285551	1
Cyclosporine	Ursodeoxycholic acid	0.289	-4.596	Minor	5 (1/4)		#97BCD9	0.491247444285171	0.292726088086751
Phenytoin	Medroxyprogesterone acetate	0.278	Inf	Moderate	2 (2/0)	The therapeutic efficacy of Medroxyprogesterone acetate can be decreased when used in combination with Phenytoin.	#B32020	0.196498977714068	1
Bisoprolol	Salmeterol	0.276	-2.489	Moderate	19 (6/13)	Bisoprolol may decrease the bronchodilatory activities of Salmeterol.	#A8C8E1	1.86674028828365	1
Sertraline	Carvedilol	0.32	-1.915	Moderate	8 (3/5)	The metabolism of Carvedilol can be decreased when combined with Sertraline.	#AECDE3	0.785995910856274	1
Carbamazepine	Itraconazole	0.186	2.031	Moderate	10 (7/3)	The serum concentration of Itraconazole can be decreased when it is combined with Carbamazepine.	#F5B4B4	0.982494888570342	1
Omeprazole	Triazolam	0.223	-1.149	Moderate	8 (4/4)		#B4D1E6	0.785995910856274	1
Losartan	Drospirenone	0.307	Inf	Moderate	6 (6/0)	Losartan may increase the hyperkalemic activities of Drospirenone.	#B32020	0.589496933142205	1
Triamcinolone	Phenobarbital	0.238	-1.723	Moderate	5 (2/3)	The metabolism of Triamcinolone can be increased when combined with Phenobarbital.	#AFCEE4	0.491247444285171	1
Diazepam	Rifampicin	0.342	-1.067	Minor	27 (14/13)	The metabolism of Diazepam can be increased when combined with Rifampicin.	#B4D1E6	2.65273619913992	1
Prednisone	Ketoconazole	0.769	1.741	Moderate	15 (10/5)	The serum concentration of Prednisone can be increased when it is combined with Ketoconazole.	#F7B7B7	1.47374233285551	1
Eletriptan	Clarithromycin	0.1	Inf	Major	8 (8/0)	The serum concentration of Eletriptan can be increased when it is combined with Clarithromycin.	#B32020	0.785995910856274	1
Metoprolol	Ergotamine	1	Inf	Moderate	1 (1/0)	Ergotamine may increase the atrioventricular blocking (AV block) activities of Metoprolol.	#B32020	0.0982494888570342	1
Fluvoxamine	Amitriptyline	0.387	2.176	Major	7 (5/2)	The risk or severity of adverse effects can be increased when Fluvoxamine is combined with Amitriptyline.	#F5B2B2	0.68774642199924	1
Estradiol	Prednisolone	0.118	Inf	Moderate	5 (5/0)	The serum concentration of Prednisolone can be increased when it is combined with Estradiol.	#B32020	0.491247444285171	1
Labetalol	Verapamil	0.25	Inf	Major	1 (1/0)	Verapamil may increase the hypotensive activities of Labetalol.	#B32020	0.0982494888570342	1
Citalopram	Pimozide	0.192	1.741	Major	3 (2/1)	The risk or severity of QTc prolongation can be increased when Citalopram is combined with Pimozide.	#F7B7B7	0.294748466571103	1
Norfloxacin	Iron	0.529	51.354	None	60 (59/1)	The serum concentration of Norfloxacin can be decreased when it is combined with Iron.	#B32020	5.89496933142205	1
Acetylsalicylic acid	Insulin glulisine	0.299	-3.447	Moderate	12 (3/9)	Acetylsalicylic acid may increase the hypoglycemic activities of Insulin Glulisine.	#A0C3DD	1.17899386628441	1
Atenolol	Terbutaline	0.251	-1.723	Moderate	15 (6/9)	Atenolol may decrease the bronchodilatory activities of Terbutaline.	#AFCEE4	1.47374233285551	1
Methylprednisolone	Rifampicin	0.339	-1.149	Moderate	6 (3/3)	The serum concentration of Methylprednisolone can be decreased when it is combined with Rifampicin.	#B4D1E6	0.589496933142205	1
Cyclosporine	Ketoconazole	1	Inf	Major	1 (1/0)	The metabolism of Cyclosporine can be decreased when combined with Ketoconazole.	#B32020	0.0982494888570342	1
Medroxyprogesterone acetate	Acenocoumarol	0.208	Inf	None	4 (4/0)	Medroxyprogesterone acetate may decrease the anticoagulant activities of Acenocoumarol.	#B32020	0.392997955428137	1
Citalopram	Warfarin	0.275	-1.149	Moderate	6 (3/3)	The metabolism of Warfarin can be decreased when combined with Citalopram.	#B4D1E6	0.589496933142205	1
Ketoconazole	Atorvastatin	0.162	Inf	Major	2 (2/0)	The serum concentration of Atorvastatin can be increased when it is combined with Ketoconazole.	#B32020	0.196498977714068	1
Lisinopril	Drospirenone	0.197	Inf	Moderate	5 (5/0)	Lisinopril may increase the hyperkalemic activities of Drospirenone.	#B32020	0.491247444285171	1
Erythromycin	Theophylline	0.704	1.741	Moderate	3 (2/1)	The metabolism of Theophylline can be decreased when combined with Erythromycin.	#F7B7B7	0.294748466571103	1
Halazepam	Itraconazole	0.417	2.611	None	4 (3/1)		#F3AFAF	0.392997955428137	1
Diazepam	Ketoconazole	0.442	1.219	Moderate	24 (14/10)	The metabolism of Diazepam can be decreased when combined with Ketoconazole.	#F8BABA	2.35798773256882	1
Pseudoephedrine	Doxepin	0.053	Inf	None	1 (1/0)	Doxepin may decrease the antihypertensive activities of Pseudoephedrine.	#B32020	0.0982494888570342	1
Imipramine	Carbamazepine	0.484	-1.149	Moderate	2 (1/1)	The metabolism of Imipramine can be increased when combined with Carbamazepine.	#B4D1E6	0.196498977714068	1
Fluconazole	Rifabutin	0.175	-6.893	Moderate	7 (1/6)	The serum concentration of Rifabutin can be increased when it is combined with Fluconazole.	#85AED1	0.68774642199924	0.0129291848617734
Fluconazole	Everolimus	0.045	Inf	Major	1 (1/0)	The serum concentration of Everolimus can be increased when it is combined with Fluconazole.	#B32020	0.0982494888570342	1
Fenofibrate	Ursodeoxycholic acid	0.535	-2.298	None	3 (1/2)	The therapeutic efficacy of Ursodeoxycholic acid can be decreased when used in combination with Fenofibrate.	#A9C9E1	0.294748466571103	1
Atenolol	Formoterol	0.316	1.161	Moderate	14 (8/6)	Atenolol may decrease the bronchodilatory activities of Formoterol.	#F9BCBC	1.37549284399848	1
Diltiazem	Tacrolimus	0.376	-2.298	Moderate	3 (1/2)	The metabolism of Tacrolimus can be decreased when combined with Diltiazem.	#A9C9E1	0.294748466571103	1
Propranolol	Terbutaline	0.292	1.596	Major	17 (11/6)		#F7B7B7	1.67024131056958	1
Carvedilol	Escitalopram	0.288	-2.681	None	10 (3/7)		#A6C7E0	0.982494888570342	1
Levothyroxine	Raloxifene	0.523	-1.149	Moderate	4 (2/2)	Raloxifene can cause a decrease in the absorption of Levothyroxine resulting in a reduced serum concentration and potentially a decrease in efficacy.	#B4D1E6	0.392997955428137	1
Fluvoxamine	Tramadol	0.192	-1.34	Major	13 (6/7)	Fluvoxamine may increase the neuroexcitatory activities of Tramadol.	#B2D0E5	1.27724335514144	1
Midazolam	Josamycin	1	Inf	None	1 (1/0)	The serum concentration of Midazolam can be increased when it is combined with Josamycin.	#B32020	0.0982494888570342	1
Ethinylestradiol	Rifampicin	0.279	Inf	Major	10 (10/0)	The metabolism of Ethinyl Estradiol can be increased when combined with Rifampicin.	#B32020	0.982494888570342	1
Dihydroergotamine	Atenolol	0.274	-1.149	Moderate	4 (2/2)	Dihydroergotamine may increase the atrioventricular blocking (AV block) activities of Atenolol.	#B4D1E6	0.392997955428137	1
Tamoxifen	Rifampicin	1	Inf	Moderate	1 (1/0)	The metabolism of Tamoxifen can be increased when combined with Rifampicin.	#B32020	0.0982494888570342	1
Ranitidine	Itraconazole	0.527	1.335	Moderate	38 (23/15)	The serum concentration of Itraconazole can be decreased when it is combined with Ranitidine.	#F8BABA	3.7334805765673	1
Cyclosporine	Ethinylestradiol	0.188	Inf	Moderate	7 (7/0)	The metabolism of Ethinyl Estradiol can be decreased when combined with Cyclosporine.	#B32020	0.68774642199924	1
Tramadol	Moclobemide	0.34	Inf	None	1 (1/0)	Tramadol may increase the neuroexcitatory activities of Moclobemide.	#B32020	0.0982494888570342	1
Fluvoxamine	Almotriptan	0.17	Inf	Major	2 (2/0)	The metabolism of Almotriptan can be decreased when combined with Fluvoxamine.	#B32020	0.196498977714068	1
Doxycycline	Iron	0.576	26.112	Moderate	31 (30/1)	Doxycycline can cause a decrease in the absorption of Iron resulting in a reduced serum concentration and potentially a decrease in efficacy.	#B32020	3.04573415456806	1
Fluoxetine	Naratriptan	0.095	Inf	Major	2 (2/0)	The risk or severity of adverse effects can be increased when Fluoxetine is combined with Naratriptan.	#B32020	0.196498977714068	1
Fluoxetine	Josamycin	0.225	5.222	None	7 (6/1)		#E99999	0.68774642199924	1
Warfarin	Levofloxacin	0.12	1.741	Major	3 (2/1)	Levofloxacin may increase the anticoagulant activities of Warfarin.	#F7B7B7	0.294748466571103	1
Desogestrel	Lamotrigine	0.269	Inf	Moderate	14 (14/0)	Desogestrel may increase the excretion rate of Lamotrigine which could result in a lower serum level and potentially a reduction in efficacy.	#B32020	1.37549284399848	1
Carbamazepine	Clarithromycin	0.203	-1.034	Major	19 (10/9)	The serum concentration of the active metabolites of Clarithromycin can be increased when Clarithromycin is used in combination with Carbamazepine.	#B4D1E6	1.86674028828365	1
Amitriptyline	Epinephrine	0.344	3.482	Major	10 (8/2)	Amitriptyline may decrease the antihypertensive activities of Epinephrine.	#F0A7A7	0.982494888570342	1
Prednisolone	Rifampicin	0.056	Inf	Moderate	1 (1/0)	The serum concentration of Prednisolone can be decreased when it is combined with Rifampicin.	#B32020	0.0982494888570342	1
Ketoconazole	Budesonide	0.626	1.492	Major	19 (12/7)	The serum concentration of Budesonide can be increased when it is combined with Ketoconazole.	#F7B9B9	1.86674028828365	1
Dihydroergotamine	Frovatriptan	0.536	-1.149	Major	2 (1/1)	Dihydroergotamine may increase the vasoconstricting activities of Frovatriptan.	#B4D1E6	0.196498977714068	1
Fluconazole	Dihydroergotamine	0.141	Inf	Moderate	7 (7/0)	The metabolism of Dihydroergotamine can be decreased when combined with Fluconazole.	#B32020	0.68774642199924	1
Duloxetine	Flecainide	0.312	-1.149	Moderate	2 (1/1)	The metabolism of Flecainide can be decreased when combined with Duloxetine.	#B4D1E6	0.196498977714068	1
Paroxetine	Moclobemide	0.188	Inf	None	1 (1/0)	The risk or severity of adverse effects can be increased when Paroxetine is combined with Moclobemide.	#B32020	0.0982494888570342	1
Cyclosporine	Clindamycin	0.189	1.306	Moderate	5 (3/2)	The metabolism of Clindamycin can be decreased when combined with Cyclosporine.	#F8BABA	0.491247444285171	1
Lidocaine	Propranolol	0.75	Inf	Moderate	3 (3/0)	The serum concentration of Lidocaine can be increased when it is combined with Propranolol.	#B32020	0.294748466571103	1
Phenytoin	Sertraline	0.181	-4.021	Moderate	9 (2/7)	The serum concentration of Phenytoin can be increased when it is combined with Sertraline.	#9CBFDB	0.884245399713308	1
Propranolol	Salmeterol	0.208	1.306	Major	15 (9/6)		#F8BABA	1.47374233285551	1
Trazodone	Itraconazole	0.444	-1.005	Moderate	15 (8/7)	The metabolism of Trazodone can be decreased when combined with Itraconazole.	#B4D1E6	1.47374233285551	1
Citalopram	Clozapine	0.302	-2.872	Major	7 (2/5)	The serum concentration of Clozapine can be increased when it is combined with Citalopram.	#A5C6DF	0.68774642199924	1
Tacrolimus	Metronidazole	0.392	3.482	Moderate	10 (8/2)		#F0A7A7	0.982494888570342	1
Tetracycline	Amoxicillin	0.589	1.82	Moderate	34 (23/11)		#F6B6B6	3.34048262113916	1
Levonorgestrel	Phenobarbital	0.296	Inf	Major	5 (5/0)	The metabolism of Levonorgestrel can be increased when combined with Phenobarbital.	#B32020	0.491247444285171	1
Fentanyl	Ketoconazole	0.046	-1.149	Major	2 (1/1)	The serum concentration of Fentanyl can be increased when it is combined with Ketoconazole.	#B4D1E6	0.196498977714068	1
Erythromycin	Eletriptan	0.364	Inf	Major	3 (3/0)	The serum concentration of Eletriptan can be increased when it is combined with Erythromycin.	#B32020	0.294748466571103	1
Codeine	Cimetidine	0.192	Inf	Moderate	2 (2/0)	The therapeutic efficacy of Codeine can be decreased when used in combination with Cimetidine.	#B32020	0.196498977714068	1
Erythromycin	Sertraline	0.312	1.368	Moderate	18 (11/7)	The risk or severity of adverse effects can be increased when Erythromycin is combined with Sertraline.	#F8BABA	1.76849079942662	1
Nabumetone	Methotrexate	0.045	Inf	Major	1 (1/0)	The serum concentration of Methotrexate can be increased when it is combined with Nabumetone.	#B32020	0.0982494888570342	1
Diclofenac	Rifampicin	0.342	-1.723	Moderate	30 (12/18)	The serum concentration of Diclofenac can be decreased when it is combined with Rifampicin.	#AFCEE4	2.94748466571103	1
Rifabutin	Clarithromycin	0.612	-4.596	Moderate	5 (1/4)	The serum concentration of the active metabolites of Clarithromycin can be increased when Clarithromycin is used in combination with Rifabutin.	#97BCD9	0.491247444285171	1
Clozapine	Bromazepam	0.481	-3.447	None	4 (1/3)	The risk or severity of adverse effects can be increased when Bromazepam is combined with Clozapine.	#A0C3DD	0.392997955428137	1
Hydrocortisone	Rifampicin	0.478	-1.532	Moderate	7 (3/4)	The serum concentration of Hydrocortisone can be decreased when it is combined with Rifampicin.	#B1CFE5	0.68774642199924	1
Metformin	Glucosamine	0.476	-1.149	None	6 (3/3)		#B4D1E6	0.589496933142205	1
Clarithromycin	Quetiapine	0.19	-1.559	Major	33 (14/19)	The serum concentration of Quetiapine can be increased when it is combined with Clarithromycin.	#AFCEE4	3.24223313228213	1
Quinapril	Drospirenone	0.25	Inf	Moderate	1 (1/0)	Quinapril may increase the hyperkalemic activities of Drospirenone.	#B32020	0.0982494888570342	1
Theophylline	Ethinylestradiol	0.097	Inf	None	5 (5/0)	The serum concentration of Theophylline can be increased when it is combined with Ethinyl Estradiol.	#B32020	0.491247444285171	1
Doxycycline	Isotretinoin	0.268	1.161	Major	7 (4/3)	The risk or severity of adverse effects can be increased when Doxycycline is combined with Isotretinoin.	#F9BCBC	0.68774642199924	1
Indomethacin	Atenolol	0.364	-1.915	Moderate	8 (3/5)	Indomethacin may decrease the antihypertensive activities of Atenolol.	#AECDE3	0.785995910856274	1
Rifampicin	Etoricoxib	0.284	1.741	None	3 (2/1)	The metabolism of Etoricoxib can be increased when combined with Rifampicin.	#F7B7B7	0.294748466571103	1
Bisoprolol	Gliclazide	0.441	-5.744	None	6 (1/5)	Bisoprolol may increase the hypoglycemic activities of Gliclazide.	#8EB5D5	0.589496933142205	1
Griseofulvin	Medroxyprogesterone acetate	0.125	Inf	Major	1 (1/0)	The serum concentration of Medroxyprogesterone acetate can be decreased when it is combined with Griseofulvin.	#B32020	0.0982494888570342	1
Phenobarbital	Dexamethasone	0.048	Inf	Moderate	1 (1/0)	The serum concentration of Dexamethasone can be decreased when it is combined with Phenobarbital.	#B32020	0.0982494888570342	1
Olmesartan	Drospirenone	0.229	Inf	Moderate	3 (3/0)	Olmesartan may increase the hyperkalemic activities of Drospirenone.	#B32020	0.294748466571103	1
Metoclopramide	Levodopa	1	Inf	Moderate	2 (2/0)	The therapeutic efficacy of Levodopa can be decreased when used in combination with Metoclopramide.	#B32020	0.196498977714068	1
Fluconazole	Celecoxib	0.479	Inf	Moderate	10 (10/0)	The metabolism of Celecoxib can be decreased when combined with Fluconazole.	#B32020	0.982494888570342	1
Medroxyprogesterone acetate	Phenobarbital	0.26	Inf	Moderate	2 (2/0)	The metabolism of Medroxyprogesterone acetate can be increased when combined with Phenobarbital.	#B32020	0.196498977714068	1
Carbamazepine	Norethisterone	0.123	Inf	Major	2 (2/0)	The metabolism of Norethisterone can be increased when combined with Carbamazepine.	#B32020	0.196498977714068	1
Ciprofloxacin	Warfarin	0.285	2.611	Major	4 (3/1)		#F3AFAF	0.392997955428137	1
Buspirone	Clarithromycin	0.125	Inf	Moderate	1 (1/0)	The metabolism of Buspirone can be decreased when combined with Clarithromycin.	#B32020	0.0982494888570342	1
Erythromycin	Quetiapine	0.123	1.044	Major	11 (6/5)	The metabolism of Quetiapine can be decreased when combined with Erythromycin.	#F9BCBC	1.08074437742738	1
Phenytoin	Clarithromycin	0.065	-2.298	Moderate	9 (3/6)	The serum concentration of the active metabolites of Clarithromycin can be increased when Clarithromycin is used in combination with Phenytoin.	#A9C9E1	0.884245399713308	1
Cyclosporine	Erythromycin	0.078	Inf	Major	2 (2/0)	The metabolism of Cyclosporine can be decreased when combined with Erythromycin.	#B32020	0.196498977714068	1
Phenylephrine	Clomipramine	0.188	-1.149	Major	2 (1/1)	Clomipramine may increase the vasopressor activities of Phenylephrine.	#B4D1E6	0.196498977714068	1
Ketoconazole	Rabeprazole	1	Inf	Moderate	2 (2/0)	The serum concentration of Ketoconazole can be decreased when it is combined with Rabeprazole.	#B32020	0.196498977714068	1
Amitriptyline	Rifampicin	0.3	-1.436	Minor	9 (4/5)	The metabolism of Amitriptyline can be increased when combined with Rifampicin.	#B1CFE5	0.884245399713308	1
Citalopram	Frovatriptan	0.231	3.482	Major	5 (4/1)	The risk or severity of adverse effects can be increased when Citalopram is combined with Frovatriptan.	#F0A7A7	0.491247444285171	1
Valsartan	Lithium cation	0.244	-3.447	Moderate	4 (1/3)	The serum concentration of Lithium can be increased when it is combined with Valsartan.	#A0C3DD	0.392997955428137	1
Fluconazole	Imipramine	0.2	2.611	Moderate	4 (3/1)	The metabolism of Imipramine can be decreased when combined with Fluconazole.	#F3AFAF	0.392997955428137	1
Warfarin	Terbinafine	0.281	-1.149	Moderate	2 (1/1)		#B4D1E6	0.196498977714068	1
Pantoprazole	Ketoconazole	0.632	1.306	Moderate	5 (3/2)	The serum concentration of Ketoconazole can be decreased when it is combined with Pantoprazole.	#F8BABA	0.491247444285171	1
Dihydroergotamine	Clarithromycin	0.63	1.523	Major	11 (7/4)	The serum concentration of Dihydroergotamine can be increased when it is combined with Clarithromycin.	#F7B9B9	1.08074437742738	1
Trospium	Amitriptyline	0.024	Inf	Moderate	1 (1/0)		#B32020	0.0982494888570342	1
Terbutaline	Clomipramine	0.188	-3.217	Moderate	19 (5/14)	The risk or severity of adverse effects can be increased when Clomipramine is combined with Terbutaline.	#A3C5DF	1.86674028828365	1
Citalopram	Josamycin	0.443	1.741	None	9 (6/3)		#F7B7B7	0.884245399713308	1
Cyclosporine	Carbamazepine	0.135	-1.149	Major	2 (1/1)	The serum concentration of Cyclosporine can be decreased when it is combined with Carbamazepine.	#B4D1E6	0.196498977714068	1
Lansoprazole	Itraconazole	0.549	-1.005	Moderate	15 (8/7)	The serum concentration of Itraconazole can be decreased when it is combined with Lansoprazole.	#B4D1E6	1.47374233285551	1
Indomethacin	Nadolol	0.376	1.741	Moderate	3 (2/1)	Indomethacin may decrease the antihypertensive activities of Nadolol.	#F7B7B7	0.294748466571103	1
Erythromycin	Methylergometrine	0.9	Inf	None	5 (5/0)	The risk or severity of adverse effects can be increased when Methylergometrine is combined with Erythromycin.	#B32020	0.491247444285171	1
Felodipine	Itraconazole	0.143	Inf	Major	1 (1/0)	The serum concentration of Felodipine can be increased when it is combined with Itraconazole.	#B32020	0.0982494888570342	1
Itraconazole	Aripiprazole	0.11	-1.608	Moderate	12 (5/7)	The serum concentration of Aripiprazole can be increased when it is combined with Itraconazole.	#AFCEE4	1.17899386628441	1
Propranolol	Maprotiline	0.519	-1.149	Minor	2 (1/1)		#B4D1E6	0.196498977714068	1
Triamcinolone	Acetylsalicylic acid	0.668	-1.477	Moderate	16 (7/9)	The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Triamcinolone.	#B1CFE5	1.57199182171255	1
Disulfiram	Acenocoumarol	0.095	-2.298	None	3 (1/2)	The serum concentration of Acenocoumarol can be increased when it is combined with Disulfiram.	#A9C9E1	0.294748466571103	1
Allopurinol	Azathioprine	0.121	-3.447	Major	4 (1/3)	The serum concentration of the active metabolites of Azathioprine can be increased when Azathioprine is used in combination with Allopurinol.	#A0C3DD	0.392997955428137	1
Digoxin	Clarithromycin	0.556	1.741	Major	3 (2/1)	The metabolism of Digoxin can be decreased when combined with Clarithromycin.	#F7B7B7	0.294748466571103	1
Nortriptyline	Salbutamol	0.209	Inf	Moderate	3 (3/0)	The risk or severity of adverse effects can be increased when Nortriptyline is combined with Salbutamol.	#B32020	0.294748466571103	1
Indomethacin	Losartan	0.154	-1.723	Moderate	5 (2/3)	The metabolism of Indomethacin can be decreased when combined with Losartan.	#AFCEE4	0.491247444285171	1
Propranolol	Repaglinide	0.059	Inf	Moderate	1 (1/0)		#B32020	0.0982494888570342	1
Ketoconazole	Clonazepam	0.364	-1.532	None	7 (3/4)	The metabolism of Clonazepam can be decreased when combined with Ketoconazole.	#B1CFE5	0.68774642199924	1
Rifampicin	Acenocoumarol	0.137	-1.149	None	2 (1/1)	The metabolism of Acenocoumarol can be increased when combined with Rifampicin.	#B4D1E6	0.196498977714068	1
Enalapril	Tizanidine	0.181	-2.298	Major	15 (5/10)	The risk or severity of hypotension can be increased when Tizanidine is combined with Enalapril.	#A9C9E1	1.47374233285551	1
Lorazepam	Phenytoin	0.366	-5.744	Moderate	18 (3/15)	The serum concentration of Phenytoin can be increased when it is combined with Lorazepam.	#8EB5D5	1.76849079942662	1
Losartan	Rifampicin	0.667	Inf	Moderate	1 (1/0)	The serum concentration of Losartan can be decreased when it is combined with Rifampicin.	#B32020	0.0982494888570342	1
Fluconazole	Rifampicin	0.556	4.352	Major	6 (5/1)	The metabolism of Rifampicin can be decreased when combined with Fluconazole.	#EC9F9F	0.589496933142205	1
Phenytoin	Fluoxetine	0.348	-5.17	Moderate	11 (2/9)	The serum concentration of Phenytoin can be increased when it is combined with Fluoxetine.	#93B8D7	1.08074437742738	1
Eprosartan	Drospirenone	0.3	Inf	Moderate	1 (1/0)	Eprosartan may increase the hyperkalemic activities of Drospirenone.	#B32020	0.0982494888570342	1
Levonorgestrel	Carbamazepine	0.127	Inf	Major	9 (9/0)	The therapeutic efficacy of Levonorgestrel can be decreased when used in combination with Carbamazepine.	#B32020	0.884245399713308	1
Atenolol	Ergotamine	0.512	1.741	Moderate	3 (2/1)	Ergotamine may increase the atrioventricular blocking (AV block) activities of Atenolol.	#F7B7B7	0.294748466571103	1
Labetalol	Terbutaline	0.07	Inf	Major	5 (5/0)	The risk or severity of adverse effects can be increased when Labetalol is combined with Terbutaline.	#B32020	0.491247444285171	1
Paroxetine	Carvedilol	0.345	-2.298	Moderate	9 (3/6)	The metabolism of Carvedilol can be decreased when combined with Paroxetine.	#A9C9E1	0.884245399713308	1
Ketoconazole	Rifampicin	0.5	Inf	Major	1 (1/0)	The metabolism of Ketoconazole can be increased when combined with Rifampicin.	#B32020	0.0982494888570342	1
Doxycycline	Phenobarbital	0.081	-4.596	Moderate	10 (2/8)	The serum concentration of Doxycycline can be decreased when it is combined with Phenobarbital.	#97BCD9	0.982494888570342	1
Oxycodone	Paroxetine	0.337	-1.532	Moderate	7 (3/4)	The metabolism of Oxycodone can be decreased when combined with Paroxetine.	#B1CFE5	0.68774642199924	1
Moxifloxacin	Warfarin	0.18	-1.149	Major	2 (1/1)		#B4D1E6	0.196498977714068	1
Fluvoxamine	Sumatriptan	0.083	1.741	Major	3 (2/1)	The risk or severity of adverse effects can be increased when Fluvoxamine is combined with Sumatriptan.	#F7B7B7	0.294748466571103	1
Lisinopril	Lithium cation	0.029	-2.298	Moderate	3 (1/2)	The serum concentration of Lithium can be increased when it is combined with Lisinopril.	#A9C9E1	0.294748466571103	1
Venlafaxine	Frovatriptan	0.093	Inf	Major	2 (2/0)	The risk or severity of adverse effects can be increased when Venlafaxine is combined with Frovatriptan.	#B32020	0.196498977714068	1
Terbutaline	Nadolol	0.333	Inf	Major	3 (3/0)		#B32020	0.294748466571103	1
Doxycycline	Rifampicin	0.759	-5.744	Moderate	18 (3/15)	The serum concentration of Doxycycline can be decreased when it is combined with Rifampicin.	#8EB5D5	1.76849079942662	1
Tetracycline	Isotretinoin	0.75	-1.149	Major	2 (1/1)		#B4D1E6	0.196498977714068	1
Formoterol	Nadolol	0.378	Inf	Major	4 (4/0)		#B32020	0.392997955428137	1
Simvastatin	Itraconazole	0.245	-2.298	Major	21 (7/14)	The serum concentration of Simvastatin can be increased when it is combined with Itraconazole.	#A9C9E1	2.06323926599772	1
Glimepiride	Pregabalin	0.294	-2.298	None	3 (1/2)	The risk or severity of heart failure can be increased when Pregabalin is combined with Glimepiride.	#A9C9E1	0.294748466571103	1
Fluconazole	Triazolam	0.5	Inf	Major	1 (1/0)	The metabolism of Triazolam can be decreased when combined with Fluconazole.	#B32020	0.0982494888570342	1
Simvastatin	Colchicine	0.321	-11.489	Major	11 (1/10)	Colchicine may increase the myopathic rhabdomyolysis activities of Simvastatin.	#5F92C1	1.08074437742738	1
Dihydroergotamine	Nadolol	0.5	Inf	Moderate	1 (1/0)	Dihydroergotamine may increase the atrioventricular blocking (AV block) activities of Nadolol.	#B32020	0.0982494888570342	1
Folic acid	Primidone	0.091	Inf	Moderate	1 (1/0)	The serum concentration of Primidone can be decreased when it is combined with Folic Acid.	#B32020	0.0982494888570342	1
Doxycycline	Carbamazepine	0.151	-2.298	Moderate	12 (4/8)	The serum concentration of Doxycycline can be decreased when it is combined with Carbamazepine.	#A9C9E1	1.17899386628441	1
Doxycycline	Insulin glulisine	0.068	1.741	Moderate	3 (2/1)		#F7B7B7	0.294748466571103	1
Diazepam	Josamycin	0.358	1.741	None	15 (10/5)		#F7B7B7	1.47374233285551	1
Digoxin	Diazepam	0.306	-2.298	Moderate	9 (3/6)		#A9C9E1	0.884245399713308	1
Propranolol	Epinephrine	0.277	3.482	Major	5 (4/1)	Epinephrine may increase the atrioventricular blocking (AV block) activities of Propranolol.	#F0A7A7	0.491247444285171	1
Fluconazole	Warfarin	0.05	Inf	Major	2 (2/0)	The serum concentration of Warfarin can be increased when it is combined with Fluconazole.	#B32020	0.196498977714068	1
Omeprazole	Chlordiazepoxide	0.5	Inf	Moderate	1 (1/0)		#B32020	0.0982494888570342	1
Warfarin	Paroxetine	0.202	Inf	Moderate	2 (2/0)	Paroxetine may increase the anticoagulant activities of Warfarin.	#B32020	0.196498977714068	1
Diclofenac	Warfarin	0.122	-1.436	Major	9 (4/5)	Diclofenac may increase the anticoagulant activities of Warfarin.	#B1CFE5	0.884245399713308	1
Rifampicin	Clarithromycin	0.561	1.088	Moderate	9 (5/4)	The serum concentration of the active metabolites of Clarithromycin can be increased when Clarithromycin is used in combination with Rifampicin.	#F9BCBC	0.884245399713308	1
Raloxifene	Estradiol	0.286	Inf	Moderate	1 (1/0)		#B32020	0.0982494888570342	1
Phenoxymethylpenicillin	Methotrexate	0.186	1.741	Major	6 (4/2)	The serum concentration of Methotrexate can be increased when it is combined with Phenoxymethylpenicillin.	#F7B7B7	0.589496933142205	1
Losartan	Lithium cation	0.312	-6.893	Moderate	7 (1/6)	The serum concentration of Lithium can be increased when it is combined with Losartan.	#85AED1	0.68774642199924	1
Pyridostigmine	Hydrocortisone	1	Inf	Moderate	1 (1/0)	The risk or severity of adverse effects can be increased when Hydrocortisone is combined with Pyridostigmine.	#B32020	0.0982494888570342	1
Ramipril	Drospirenone	0.333	Inf	Moderate	3 (3/0)	Ramipril may increase the hyperkalemic activities of Drospirenone.	#B32020	0.294748466571103	1
Pseudoephedrine	Bromocriptine	0.347	Inf	Moderate	4 (4/0)	Bromocriptine may increase the hypertensive and vasoconstricting activities of Pseudoephedrine.	#B32020	0.392997955428137	1
Propranolol	Verapamil	0.714	-2.298	Major	3 (1/2)	The metabolism of Propranolol can be decreased when combined with Verapamil.	#A9C9E1	0.294748466571103	1
Sucralfate	Ketoconazole	1	Inf	Minor	1 (1/0)	Sucralfate can cause a decrease in the absorption of Ketoconazole resulting in a reduced serum concentration and potentially a decrease in efficacy.	#B32020	0.0982494888570342	1
Fluvoxamine	Rizatriptan	0.049	Inf	Major	2 (2/0)	The metabolism of Rizatriptan can be decreased when combined with Fluvoxamine.	#B32020	0.196498977714068	1
Propranolol	Glyburide	0.375	-1.149	Moderate	2 (1/1)	Propranolol may increase the hypoglycemic activities of Glyburide.	#B4D1E6	0.196498977714068	1
Atorvastatin	Clarithromycin	0.24	-2.79	Major	24 (7/17)	The serum concentration of Atorvastatin can be increased when it is combined with Clarithromycin.	#A6C7E0	2.35798773256882	1
Erythromycin	Verapamil	1	Inf	Major	1 (1/0)	The metabolism of Verapamil can be decreased when combined with Erythromycin.	#B32020	0.0982494888570342	1
Erythromycin	Carbamazepine	0.111	1.306	Major	5 (3/2)	The metabolism of Carbamazepine can be decreased when combined with Erythromycin.	#F8BABA	0.491247444285171	1
Clozapine	Alprazolam	0.293	-3.447	Major	8 (2/6)	The risk or severity of adverse effects can be increased when Alprazolam is combined with Clozapine.	#A0C3DD	0.785995910856274	1
Medroxyprogesterone acetate	Warfarin	0.5	Inf	None	1 (1/0)	Medroxyprogesterone acetate may decrease the anticoagulant activities of Warfarin.	#B32020	0.0982494888570342	1
Azithromycin	Warfarin	0.089	-1.149	Moderate	6 (3/3)	The metabolism of Warfarin can be decreased when combined with Azithromycin.	#B4D1E6	0.589496933142205	1
Warfarin	Norfloxacin	0.078	Inf	Major	2 (2/0)	Norfloxacin may increase the anticoagulant activities of Warfarin.	#B32020	0.196498977714068	1
Azithromycin	Lovastatin	0.292	Inf	Moderate	2 (2/0)	The serum concentration of Lovastatin can be increased when it is combined with Azithromycin.	#B32020	0.196498977714068	1
Disulfiram	Metronidazole	0.239	-2.681	Major	10 (3/7)	The risk or severity of adverse effects can be increased when Disulfiram is combined with Metronidazole.	#A6C7E0	0.982494888570342	1
Epinephrine	Clomipramine	0.171	Inf	Major	2 (2/0)	Clomipramine may decrease the antihypertensive activities of Epinephrine.	#B32020	0.196498977714068	1
Paroxetine	Propafenone	0.375	Inf	Moderate	1 (1/0)	The serum concentration of Propafenone can be increased when it is combined with Paroxetine.	#B32020	0.0982494888570342	1
Warfarin	Clarithromycin	0.2	Inf	Major	2 (2/0)	The metabolism of Warfarin can be decreased when combined with Clarithromycin.	#B32020	0.196498977714068	1
Frovatriptan	Sertraline	0.138	Inf	Major	2 (2/0)	The risk or severity of adverse effects can be increased when Frovatriptan is combined with Sertraline.	#B32020	0.196498977714068	1
Itraconazole	Josamycin	0.611	Inf	None	3 (3/0)		#B32020	0.294748466571103	1
Methylprednisolone	Itraconazole	0.618	2.611	Major	8 (6/2)	The serum concentration of Methylprednisolone can be increased when it is combined with Itraconazole.	#F3AFAF	0.785995910856274	1
Griseofulvin	Estradiol	0.5	Inf	Moderate	1 (1/0)	The metabolism of Estradiol can be increased when combined with Griseofulvin.	#B32020	0.0982494888570342	1
Moxifloxacin	Sucralfate	0.625	Inf	Moderate	2 (2/0)		#B32020	0.196498977714068	1
Erythromycin	Zafirlukast	1	Inf	Moderate	1 (1/0)	The serum concentration of Zafirlukast can be decreased when it is combined with Erythromycin.	#B32020	0.0982494888570342	1
Metronidazole	Acenocoumarol	0.114	-1.149	None	6 (3/3)	The serum concentration of Acenocoumarol can be increased when it is combined with Metronidazole.	#B4D1E6	0.589496933142205	1
Levofloxacin	Iron	0.544	3.482	Moderate	25 (20/5)	The serum concentration of Levofloxacin can be decreased when it is combined with Iron.	#F0A7A7	2.45623722142586	1
Eplerenone	Clarithromycin	0.5	Inf	Major	1 (1/0)	The serum concentration of Eplerenone can be increased when it is combined with Clarithromycin.	#B32020	0.0982494888570342	1
Methotrexate	Tetracycline	0.087	-1.149	Moderate	2 (1/1)		#B4D1E6	0.196498977714068	1
Bisoprolol	Rifampicin	0.125	Inf	Moderate	1 (1/0)	The metabolism of Bisoprolol can be increased when combined with Rifampicin.	#B32020	0.0982494888570342	1
Ciprofloxacin	Tizanidine	0.444	-2.642	Major	33 (10/23)	Tizanidine may increase the QTc-prolonging activities of Ciprofloxacin.	#A8C8E1	3.24223313228213	1
Alprazolam	Cimetidine	1	-3.447	Moderate	4 (1/3)		#A0C3DD	0.392997955428137	1
Sucralfate	Ciprofloxacin	0.45	-1.608	Moderate	12 (5/7)		#AFCEE4	1.17899386628441	1
Carbamazepine	Ketoconazole	0.357	Inf	Moderate	1 (1/0)	The metabolism of Ketoconazole can be increased when combined with Carbamazepine.	#B32020	0.0982494888570342	1
Dexamethasone	Acenocoumarol	0.142	-1.149	None	2 (1/1)		#B4D1E6	0.196498977714068	1
Ergotamine	Clarithromycin	0.667	-1.149	Major	12 (6/6)	The serum concentration of Ergotamine can be increased when it is combined with Clarithromycin.	#B4D1E6	1.17899386628441	1
Citalopram	Carvedilol	0.273	-4.596	Moderate	10 (2/8)	The metabolism of Carvedilol can be decreased when combined with Citalopram.	#97BCD9	0.982494888570342	1
Paroxetine	Pimozide	0.302	-3.447	Major	4 (1/3)	The serum concentration of Pimozide can be increased when it is combined with Paroxetine.	#A0C3DD	0.392997955428137	1
Atorvastatin	Fusidic acid	0.536	-1.149	None	2 (1/1)	The serum concentration of Atorvastatin can be increased when it is combined with Fusidic Acid.	#B4D1E6	0.196498977714068	1
Salbutamol	Nadolol	0.207	2.176	Major	7 (5/2)		#F5B2B2	0.68774642199924	1
Phenytoin	Ciprofloxacin	0.106	-5.17	Moderate	11 (2/9)	The therapeutic efficacy of Phenytoin can be decreased when used in combination with Ciprofloxacin.	#93B8D7	1.08074437742738	1
Fluconazole	Ergotamine	0.185	Inf	Moderate	5 (5/0)	The metabolism of Ergotamine can be decreased when combined with Fluconazole.	#B32020	0.491247444285171	1
Methotrexate	Cloxacillin	0.209	1.161	Major	7 (4/3)	The serum concentration of Methotrexate can be increased when it is combined with Cloxacillin.	#F9BCBC	0.68774642199924	1
Erythromycin	Itraconazole	0.69	-1.532	Major	14 (6/8)	The metabolism of Erythromycin can be decreased when combined with Itraconazole.	#B1CFE5	1.37549284399848	1
Doxycycline	Insulin aspart	0.067	-2.585	Moderate	13 (4/9)		#A8C8E1	1.27724335514144	1
Thiethylperazine	Levofloxacin	0.412	Inf	None	5 (5/0)		#B32020	0.491247444285171	1
Atorvastatin	Josamycin	0.125	Inf	None	1 (1/0)	The risk or severity of adverse effects can be increased when Josamycin is combined with Atorvastatin.	#B32020	0.0982494888570342	1
Carbamazepine	Isoniazid	0.5	Inf	Moderate	1 (1/0)	The metabolism of Carbamazepine can be decreased when combined with Isoniazid.	#B32020	0.0982494888570342	1
Sucralfate	Norfloxacin	0.75	3.482	Moderate	5 (4/1)	The serum concentration of Norfloxacin can be decreased when it is combined with Sucralfate.	#F0A7A7	0.491247444285171	1
Ethinylestradiol	Acenocoumarol	0.271	Inf	None	5 (5/0)	Ethinyl Estradiol may decrease the anticoagulant activities of Acenocoumarol.	#B32020	0.491247444285171	1
Ethinylestradiol	Pioglitazone	0.167	Inf	Minor	1 (1/0)	The therapeutic efficacy of Pioglitazone can be decreased when used in combination with Ethinyl Estradiol.	#B32020	0.0982494888570342	1
Prednisolone	Ethinylestradiol	0.176	Inf	Moderate	4 (4/0)	The serum concentration of Prednisolone can be increased when it is combined with Ethinyl Estradiol.	#B32020	0.392997955428137	1
Salmeterol	Carvedilol	0.175	-4.596	Major	5 (1/4)	Carvedilol may decrease the vasoconstricting activities of Salmeterol.	#97BCD9	0.491247444285171	1
Ergotamine	Josamycin	0.167	Inf	None	1 (1/0)	The risk or severity of adverse effects can be increased when Ergotamine is combined with Josamycin.	#B32020	0.0982494888570342	1
Pimozide	Clarithromycin	0.037	-1.149	Major	2 (1/1)	The risk or severity of ventricular arrhythmias can be increased when Clarithromycin is combined with Pimozide.	#B4D1E6	0.196498977714068	1
Metoprolol	Sertraline	0.25	Inf	Moderate	1 (1/0)	The serum concentration of Metoprolol can be increased when it is combined with Sertraline.	#B32020	0.0982494888570342	1
Erythromycin	Bromocriptine	0.55	Inf	Moderate	2 (2/0)	The risk or severity of adverse effects can be increased when Bromocriptine is combined with Erythromycin.	#B32020	0.196498977714068	1
Lovastatin	Clarithromycin	0.091	Inf	Major	1 (1/0)	The serum concentration of Lovastatin can be increased when it is combined with Clarithromycin.	#B32020	0.0982494888570342	1
Labetalol	Formoterol	0.411	Inf	Major	4 (4/0)	Labetalol may decrease the vasoconstricting activities of Formoterol.	#B32020	0.392997955428137	1
Fluconazole	Midazolam	0.099	1.741	Major	3 (2/1)	The metabolism of Midazolam can be decreased when combined with Fluconazole.	#F7B7B7	0.294748466571103	1
Dihydroergotamine	Labetalol	0.029	Inf	Moderate	1 (1/0)	Dihydroergotamine may increase the atrioventricular blocking (AV block) activities of Labetalol.	#B32020	0.0982494888570342	1
Tetracycline	Iron	0.833	Inf	Moderate	4 (4/0)		#B32020	0.392997955428137	1
Fluconazole	Tolterodine	0.198	Inf	Moderate	2 (2/0)	The metabolism of Tolterodine can be decreased when combined with Fluconazole.	#B32020	0.196498977714068	1
Almotriptan	Ketoconazole	1	Inf	Moderate	1 (1/0)	The serum concentration of Almotriptan can be increased when it is combined with Ketoconazole.	#B32020	0.0982494888570342	1
Cimetidine	Diazepam	0.167	Inf	Moderate	1 (1/0)	The metabolism of Diazepam can be decreased when combined with Cimetidine.	#B32020	0.0982494888570342	1
Cyclosporine	Diclofenac	0.205	-2.011	Moderate	11 (4/7)	Diclofenac may increase the nephrotoxic activities of Cyclosporine.	#ACCCE3	1.08074437742738	1
Acenocoumarol	Etoricoxib	0.278	Inf	None	1 (1/0)	Etoricoxib may increase the anticoagulant activities of Acenocoumarol.	#B32020	0.0982494888570342	1
Minocycline	Acenocoumarol	0.065	Inf	None	1 (1/0)	Minocycline may increase the anticoagulant activities of Acenocoumarol.	#B32020	0.0982494888570342	1
Citalopram	Naratriptan	0.5	Inf	Major	1 (1/0)	The risk or severity of adverse effects can be increased when Citalopram is combined with Naratriptan.	#B32020	0.0982494888570342	1
Ramipril	Tizanidine	0.027	-1.149	Major	2 (1/1)	The risk or severity of hypotension can be increased when Tizanidine is combined with Ramipril.	#B4D1E6	0.196498977714068	1
Fluconazole	Haloperidol	0.268	1.741	Major	3 (2/1)	The metabolism of Haloperidol can be decreased when combined with Fluconazole.	#F7B7B7	0.294748466571103	1
Sucralfate	Itraconazole	0.68	-4.021	None	9 (2/7)	Sucralfate can cause a decrease in the absorption of Itraconazole resulting in a reduced serum concentration and potentially a decrease in efficacy.	#9CBFDB	0.884245399713308	1
Dihydroergotamine	Itraconazole	0.367	Inf	Major	2 (2/0)	The serum concentration of Dihydroergotamine can be increased when it is combined with Itraconazole.	#B32020	0.196498977714068	1
Dihydroergotamine	Nitroglycerin	1	Inf	Moderate	1 (1/0)	The bioavailability of Dihydroergotamine can be increased when combined with Nitroglycerin.	#B32020	0.0982494888570342	1
Isotretinoin	Minocycline	0.252	-2.298	Major	3 (1/2)	The risk or severity of adverse effects can be increased when Minocycline is combined with Isotretinoin.	#A9C9E1	0.294748466571103	1
Indomethacin	Acenocoumarol	0.138	-2.298	None	3 (1/2)	Indomethacin may increase the anticoagulant activities of Acenocoumarol.	#A9C9E1	0.294748466571103	1
Trospium	Cetirizine	0.176	Inf	None	1 (1/0)		#B32020	0.0982494888570342	1
Captopril	Drospirenone	0.071	Inf	Moderate	1 (1/0)	Captopril may increase the hyperkalemic activities of Drospirenone.	#B32020	0.0982494888570342	1
Imipramine	Pseudoephedrine	0.125	Inf	None	1 (1/0)	Imipramine may decrease the antihypertensive activities of Pseudoephedrine.	#B32020	0.0982494888570342	1
Midazolam	Clarithromycin	0.357	-1.723	Moderate	5 (2/3)	The serum concentration of Midazolam can be increased when it is combined with Clarithromycin.	#AFCEE4	0.491247444285171	1
Metoprolol	Fluoxetine	0.05	Inf	Moderate	1 (1/0)	The serum concentration of Metoprolol can be increased when it is combined with Fluoxetine.	#B32020	0.0982494888570342	1
Telmisartan	Drospirenone	0.667	Inf	Moderate	1 (1/0)	Telmisartan may increase the hyperkalemic activities of Drospirenone.	#B32020	0.0982494888570342	1
Lithium cation	Etoricoxib	0.053	-2.298	None	3 (1/2)	The serum concentration of Lithium can be increased when it is combined with Etoricoxib.	#A9C9E1	0.294748466571103	1
Rabeprazole	Itraconazole	0.532	-2.298	Moderate	9 (3/6)	The serum concentration of Itraconazole can be decreased when it is combined with Rabeprazole.	#A9C9E1	0.884245399713308	1
Flurazepam	Itraconazole	0.545	-1.149	None	2 (1/1)	The metabolism of Flurazepam can be decreased when combined with Itraconazole.	#B4D1E6	0.196498977714068	1
Sucralfate	Levofloxacin	0.523	-2.872	Moderate	7 (2/5)	The serum concentration of Levofloxacin can be decreased when it is combined with Sucralfate.	#A5C6DF	0.68774642199924	1
Ethinylestradiol	Ketoconazole	0.444	Inf	Moderate	4 (4/0)	The metabolism of Ethinyl Estradiol can be decreased when combined with Ketoconazole.	#B32020	0.392997955428137	1
Imipramine	Salbutamol	0.223	-1.723	Moderate	5 (2/3)	The risk or severity of adverse effects can be increased when Imipramine is combined with Salbutamol.	#AFCEE4	0.491247444285171	1
Hydrocortisone	Cholestyramine	0.077	Inf	Moderate	1 (1/0)	Cholestyramine can cause a decrease in the absorption of Hydrocortisone resulting in a reduced serum concentration and potentially a decrease in efficacy.	#B32020	0.0982494888570342	1
Metoprolol	Formoterol	0.133	-1.149	Moderate	2 (1/1)	The metabolism of Formoterol can be decreased when combined with Metoprolol.	#B4D1E6	0.196498977714068	1
Terbinafine	Rifampicin	0.583	-1.149	Minor	2 (1/1)	The serum concentration of Terbinafine can be decreased when it is combined with Rifampicin.	#B4D1E6	0.196498977714068	1
Alprazolam	Josamycin	0.338	3.482	None	5 (4/1)	The serum concentration of Alprazolam can be increased when it is combined with Josamycin.	#F0A7A7	0.491247444285171	1
Simvastatin	Rifampicin	0.455	Inf	Major	1 (1/0)	The metabolism of Simvastatin can be increased when combined with Rifampicin.	#B32020	0.0982494888570342	1
Alprazolam	Telithromycin	0.514	-1.149	Moderate	2 (1/1)	The serum concentration of Alprazolam can be increased when it is combined with Telithromycin.	#B4D1E6	0.196498977714068	1
Indomethacin	Lithium cation	0.341	-1.149	Major	2 (1/1)	The serum concentration of Lithium can be increased when it is combined with Indomethacin.	#B4D1E6	0.196498977714068	1
Itraconazole	Phenobarbital	0.246	-2.298	Moderate	3 (1/2)	The serum concentration of Itraconazole can be decreased when it is combined with Phenobarbital.	#A9C9E1	0.294748466571103	1
Labetalol	Salmeterol	0.361	Inf	Major	2 (2/0)	Labetalol may decrease the vasoconstricting activities of Salmeterol.	#B32020	0.196498977714068	1
Erythromycin	Tacrolimus	0.548	1.741	Major	3 (2/1)	The serum concentration of Tacrolimus can be increased when it is combined with Erythromycin.	#F7B7B7	0.294748466571103	1
Dextromethorphan	Terbinafine	0.74	-1.379	Major	11 (5/6)	The metabolism of Dextromethorphan can be decreased when combined with Terbinafine.	#B1CFE5	1.08074437742738	1
Ampicillin	Ethinylestradiol	0.105	Inf	Moderate	3 (3/0)		#B32020	0.294748466571103	1
Acetylsalicylic acid	Ginkgo biloba	0.542	-2.298	Moderate	3 (1/2)	Ginkgo biloba may increase the anticoagulant activities of Acetylsalicylic acid.	#A9C9E1	0.294748466571103	1
Lansoprazole	Ketoconazole	0.126	-3.447	Moderate	4 (1/3)	The serum concentration of Ketoconazole can be decreased when it is combined with Lansoprazole.	#A0C3DD	0.392997955428137	1
Simvastatin	Ketoconazole	0.29	-4.596	Major	5 (1/4)	The serum concentration of Simvastatin can be increased when it is combined with Ketoconazole.	#97BCD9	0.491247444285171	1
Atenolol	Epinephrine	0.167	Inf	Moderate	1 (1/0)	Epinephrine may increase the atrioventricular blocking (AV block) activities of Atenolol.	#B32020	0.0982494888570342	1
Labetalol	Ergotamine	0.036	Inf	Moderate	1 (1/0)	Ergotamine may increase the atrioventricular blocking (AV block) activities of Labetalol.	#B32020	0.0982494888570342	1
Simvastatin	Fusidic acid	0.092	-2.298	None	3 (1/2)	The serum concentration of Simvastatin can be increased when it is combined with Fusidic Acid.	#A9C9E1	0.294748466571103	1
Esomeprazole	Itraconazole	0.288	-2.298	Moderate	9 (3/6)	The serum concentration of Itraconazole can be decreased when it is combined with Esomeprazole.	#A9C9E1	0.884245399713308	1
Midazolam	Itraconazole	0.55	-1.149	Major	2 (1/1)	The serum concentration of Midazolam can be increased when it is combined with Itraconazole.	#B4D1E6	0.196498977714068	1
Amitriptyline	Phenylephrine	0.111	Inf	Major	1 (1/0)	Amitriptyline may increase the vasopressor activities of Phenylephrine.	#B32020	0.0982494888570342	1
Omeprazole	Quazepam	0.591	-3.447	Moderate	4 (1/3)	The metabolism of Quazepam can be decreased when combined with Omeprazole.	#A0C3DD	0.392997955428137	1
Cyclosporine	Itraconazole	0.25	-1.149	Major	2 (1/1)	The metabolism of Cyclosporine can be decreased when combined with Itraconazole.	#B4D1E6	0.196498977714068	1
Atorvastatin	Itraconazole	0.266	-2.298	Major	6 (2/4)	The risk or severity of adverse effects can be increased when Itraconazole is combined with Atorvastatin.	#A9C9E1	0.589496933142205	1
Oxytetracycline	Amoxicillin	0.225	-1.149	Moderate	2 (1/1)		#B4D1E6	0.196498977714068	1
Tolterodine	Itraconazole	0.143	Inf	Moderate	1 (1/0)	The serum concentration of Tolterodine can be increased when it is combined with Itraconazole.	#B32020	0.0982494888570342	1
Metoprolol	Paroxetine	0.154	Inf	Moderate	1 (1/0)	The serum concentration of Metoprolol can be increased when it is combined with Paroxetine.	#B32020	0.0982494888570342	1
Tacrolimus	Clarithromycin	0.397	-1.723	Major	10 (4/6)	The serum concentration of Tacrolimus can be increased when it is combined with Clarithromycin.	#AFCEE4	0.982494888570342	1
Ethinylestradiol	Phenobarbital	0.583	Inf	Major	2 (2/0)	The metabolism of Ethinyl Estradiol can be increased when combined with Phenobarbital.	#B32020	0.196498977714068	1
Ethinylestradiol	Ursodeoxycholic acid	0.502	Inf	None	3 (3/0)	The therapeutic efficacy of Ursodeoxycholic acid can be decreased when used in combination with Ethinyl Estradiol.	#B32020	0.294748466571103	1
Ergotamine	Itraconazole	0.315	Inf	Major	2 (2/0)	The serum concentration of Ergotamine can be increased when it is combined with Itraconazole.	#B32020	0.196498977714068	1
Doxycycline	Insulin detemir	0.125	Inf	Moderate	1 (1/0)		#B32020	0.0982494888570342	1
Ergotamine	Nitroglycerin	0.5	Inf	Moderate	1 (1/0)	The bioavailability of Ergotamine can be increased when combined with Nitroglycerin.	#B32020	0.0982494888570342	1
Prednisolone	Acetylsalicylic acid	0.202	-1.149	Moderate	2 (1/1)	The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Prednisolone.	#B4D1E6	0.196498977714068	1
Moxifloxacin	Josamycin	1	Inf	None	1 (1/0)		#B32020	0.0982494888570342	1
Thiethylperazine	Bromocriptine	1	Inf	Moderate	1 (1/0)		#B32020	0.0982494888570342	1
Labetalol	Epinephrine	0.125	Inf	Major	1 (1/0)	Epinephrine may increase the atrioventricular blocking (AV block) activities of Labetalol.	#B32020	0.0982494888570342	1
Erythromycin	Acenocoumarol	0.1	Inf	None	1 (1/0)	The serum concentration of Acenocoumarol can be increased when it is combined with Erythromycin.	#B32020	0.0982494888570342	1
Modafinil	Ethinylestradiol	0.103	Inf	Moderate	1 (1/0)	The serum concentration of Ethinyl Estradiol can be decreased when it is combined with Modafinil.	#B32020	0.0982494888570342	1
Doxycycline	Ampicillin	1	Inf	Moderate	1 (1/0)	The therapeutic efficacy of Ampicillin can be decreased when used in combination with Doxycycline.	#B32020	0.0982494888570342	1
Prednisolone	Itraconazole	1	Inf	Moderate	1 (1/0)	The serum concentration of Prednisolone can be increased when it is combined with Itraconazole.	#B32020	0.0982494888570342	1
Moxifloxacin	Iron	0.469	2.611	Moderate	8 (6/2)		#F3AFAF	0.785995910856274	1
Tizanidine	Norethisterone	0.5	Inf	Major	1 (1/0)		#B32020	0.0982494888570342	1
Conjugated estrogens	Prednisone	0.5	Inf	Moderate	1 (1/0)	The serum concentration of Prednisone can be increased when it is combined with Conjugated estrogens.	#B32020	0.0982494888570342	1
Clarithromycin	Colchicine	0.143	Inf	Major	1 (1/0)	The serum concentration of Colchicine can be increased when it is combined with Clarithromycin.	#B32020	0.0982494888570342	1
Almotriptan	Itraconazole	0.068	Inf	Moderate	2 (2/0)	The serum concentration of Almotriptan can be increased when it is combined with Itraconazole.	#B32020	0.196498977714068	1
Erythromycin	Dihydroergotamine	0.75	-1.149	Major	2 (1/1)	The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Erythromycin.	#B4D1E6	0.196498977714068	1
Phenoxymethylpenicillin	Minocycline	0.377	-1.149	Moderate	4 (2/2)	The therapeutic efficacy of Phenoxymethylpenicillin can be decreased when used in combination with Minocycline.	#B4D1E6	0.392997955428137	1
Itraconazole	Solifenacin	0.5	Inf	Major	1 (1/0)	The metabolism of Solifenacin can be decreased when combined with Itraconazole.	#B32020	0.0982494888570342	1
Methylergometrine	Nitroglycerin	1	-1.149	Moderate	2 (1/1)	The bioavailability of Methylergometrine can be increased when combined with Nitroglycerin.	#B4D1E6	0.196498977714068	1
Theophylline	Norfloxacin	0.077	Inf	Moderate	1 (1/0)	The metabolism of Theophylline can be decreased when combined with Norfloxacin.	#B32020	0.0982494888570342	1
Eletriptan	Itraconazole	0.136	-1.149	Major	2 (1/1)	The serum concentration of Eletriptan can be increased when it is combined with Itraconazole.	#B4D1E6	0.196498977714068	1
Doxycycline	Acenocoumarol	0.362	-4.596	None	5 (1/4)	The metabolism of Acenocoumarol can be decreased when combined with Doxycycline.	#97BCD9	0.491247444285171	1
Rifampicin	Itraconazole	0.333	Inf	Major	1 (1/0)	The serum concentration of Itraconazole can be decreased when it is combined with Rifampicin.	#B32020	0.0982494888570342	1
Doxycycline	Phenoxymethylpenicillin	0.806	-1.149	Moderate	6 (3/3)	The therapeutic efficacy of Phenoxymethylpenicillin can be decreased when used in combination with Doxycycline.	#B4D1E6	0.589496933142205	1
Itraconazole	Acenocoumarol	0.148	-1.149	None	2 (1/1)	The serum concentration of Acenocoumarol can be increased when it is combined with Itraconazole.	#B4D1E6	0.196498977714068	1
Metoprolol	Salbutamol	0.183	-1.149	Moderate	2 (1/1)	Metoprolol may decrease the bronchodilatory activities of Salbutamol.	#B4D1E6	0.196498977714068	1
Erythromycin	Atorvastatin	0.229	-1.149	Major	2 (1/1)	The serum concentration of Atorvastatin can be increased when it is combined with Erythromycin.	#B4D1E6	0.196498977714068	1
Erythromycin	Ergotamine	0.5	Inf	Major	1 (1/0)	The risk or severity of adverse effects can be increased when Ergotamine is combined with Erythromycin.	#B32020	0.0982494888570342	1
Amitriptyline	Ketoconazole	0.472	-2.298	Moderate	3 (1/2)	The metabolism of Amitriptyline can be decreased when combined with Ketoconazole.	#A9C9E1	0.294748466571103	1
Cyclosporine	Clarithromycin	0.043	Inf	Major	1 (1/0)	The metabolism of Cyclosporine can be decreased when combined with Clarithromycin.	#B32020	0.0982494888570342	1
Warfarin	Naproxen	0.438	-2.298	Major	3 (1/2)	Naproxen may increase the anticoagulant activities of Warfarin.	#A9C9E1	0.294748466571103	1
Minocycline	Iron	0.248	Inf	Moderate	3 (3/0)	Minocycline can cause a decrease in the absorption of Iron resulting in a reduced serum concentration and potentially a decrease in efficacy.	#B32020	0.294748466571103	1
Cloxacillin	Acenocoumarol	0.172	-8.042	None	8 (1/7)	Cloxacillin may decrease the anticoagulant activities of Acenocoumarol.	#7AA6CD	0.785995910856274	1
Codeine	Naltrexone	0.201	-5.744	Major	6 (1/5)	The therapeutic efficacy of Codeine can be decreased when used in combination with Naltrexone.	#8EB5D5	0.589496933142205	1
Risperidone	Itraconazole	0.073	-19.531	None	18 (1/17)	The metabolism of Risperidone can be decreased when combined with Itraconazole.	#1E61A5	1.76849079942662	1
Fluconazole	Acenocoumarol	0.071	-2.298	None	3 (1/2)	The serum concentration of Acenocoumarol can be increased when it is combined with Fluconazole.	#A9C9E1	0.294748466571103	1
Trospium	Tolterodine	0.269	-Inf	Moderate	2 (0/2)	The risk or severity of adverse effects can be increased when Trospium is combined with Tolterodine.	#1E61A5	0.196498977714068	0.349631688222513
Digoxin	Propafenone	1	-Inf	Moderate	2 (0/2)	The serum concentration of Digoxin can be increased when it is combined with Propafenone.	#1E61A5	0.196498977714068	0.0931996544222362
Spironolactone	Eplerenone	0.119	-Inf	Major	4 (0/4)	Eplerenone may increase the hyperkalemic activities of Spironolactone.	#1E61A5	0.392997955428137	0.000941773676769259
Dextropropoxyphene	Naltrexone	0.368	-Inf	None	6 (0/6)	The therapeutic efficacy of Dextropropoxyphene can be decreased when used in combination with Naltrexone.	#1E61A5	0.589496933142205	2.46133395099651e-07
Ziprasidone	Chlorpromazine	0.151	-Inf	Major	6 (0/6)	Chlorpromazine may increase the QTc-prolonging activities of Ziprasidone.	#1E61A5	0.589496933142205	1.60285770153662e-05
Galantamine	Quetiapine	0.517	-Inf	Moderate	2 (0/2)	Galantamine may increase the QTc-prolonging activities of Quetiapine.	#1E61A5	0.196498977714068	0.112563707453496
Phenytoin	Sulfadiazine	0.2	-Inf	Moderate	1 (0/1)	The metabolism of Sulfadiazine can be increased when combined with Phenytoin.	#1E61A5	0.0982494888570342	1
Fenofibrate	Fluvastatin	0.492	-Inf	Major	7 (0/7)	The risk or severity of myopathy and rhabdomyolysis can be increased when Fenofibrate is combined with Fluvastatin.	#1E61A5	0.68774642199924	0.00145118060430749
Disopyramide	Bisoprolol	0.053	-Inf	Major	1 (0/1)	Disopyramide may increase the bradycardic activities of Bisoprolol.	#1E61A5	0.0982494888570342	1
Dapsone	Rifampicin	1	-Inf	Moderate	1 (0/1)	The metabolism of Dapsone can be increased when combined with Rifampicin.	#1E61A5	0.0982494888570342	1
Warfarin	Propafenone	0.286	-Inf	Moderate	1 (0/1)	The serum concentration of Warfarin can be increased when it is combined with Propafenone.	#1E61A5	0.0982494888570342	1
Disopyramide	Propranolol	0.884	-Inf	Major	1 (0/1)	Disopyramide may increase the bradycardic activities of Propranolol.	#1E61A5	0.0982494888570342	1
Fluvoxamine	Rasagiline	0.069	-Inf	Major	1 (0/1)	The serum concentration of Rasagiline can be increased when it is combined with Fluvoxamine.	#1E61A5	0.0982494888570342	1
Lovastatin	Diltiazem	1	-Inf	Major	1 (0/1)	The serum concentration of Lovastatin can be increased when it is combined with Diltiazem.	#1E61A5	0.0982494888570342	1
Spironolactone	Quinapril	0.767	-Inf	Major	1 (0/1)	The risk or severity of adverse effects can be increased when Spironolactone is combined with Quinapril.	#1E61A5	0.0982494888570342	1
Galantamine	Risperidone	0.111	-Inf	Moderate	1 (0/1)		#1E61A5	0.0982494888570342	1
Haloperidol	Glycopyrronium	0.174	-Inf	Moderate	2 (0/2)	The serum concentration of Haloperidol can be decreased when it is combined with Glycopyrronium.	#1E61A5	0.196498977714068	1
Glimepiride	Gemfibrozil	0.369	-Inf	Moderate	5 (0/5)	The metabolism of Glimepiride can be decreased when combined with Gemfibrozil.	#1E61A5	0.491247444285171	0.272151249552457
Digoxin	Indapamide	1	-Inf	Moderate	1 (0/1)	The risk or severity of adverse effects can be increased when Indapamide is combined with Digoxin.	#1E61A5	0.0982494888570342	1
Cyclosporine	Repaglinide	0.16	-Inf	Major	2 (0/2)	The serum concentration of Repaglinide can be increased when it is combined with Cyclosporine.	#1E61A5	0.196498977714068	1
Phenytoin	Levodopa	0.795	-Inf	Moderate	1 (0/1)	The therapeutic efficacy of Levodopa can be decreased when used in combination with Phenytoin.	#1E61A5	0.0982494888570342	1
Clozapine	Modafinil	0.048	-Inf	Moderate	1 (0/1)	The metabolism of Clozapine can be decreased when combined with Modafinil.	#1E61A5	0.0982494888570342	1
Trospium	Risperidone	0.193	-Inf	Moderate	2 (0/2)		#1E61A5	0.196498977714068	1
Cyclosporine	Ezetimibe	0.131	-Inf	Moderate	3 (0/3)	The serum concentration of Cyclosporine can be increased when it is combined with Ezetimibe.	#1E61A5	0.294748466571103	1
Spironolactone	Lisinopril	0.724	-Inf	Major	4 (0/4)	The risk or severity of adverse effects can be increased when Spironolactone is combined with Lisinopril.	#1E61A5	0.392997955428137	1
Verapamil	Atorvastatin	0.517	-Inf	Moderate	6 (0/6)	Atorvastatin can cause a decrease in the absorption of Verapamil resulting in a reduced serum concentration and potentially a decrease in efficacy.	#1E61A5	0.589496933142205	1
Bisoprolol	Glyburide	0.218	-Inf	Moderate	4 (0/4)	Bisoprolol may increase the hypoglycemic activities of Glyburide.	#1E61A5	0.392997955428137	1
Fluvoxamine	Ropinirole	0.077	-Inf	Moderate	1 (0/1)	Fluvoxamine may increase the sedative activities of Ropinirole.	#1E61A5	0.0982494888570342	1
Fluvoxamine	Imipramine	0.12	-Inf	Major	2 (0/2)	The risk or severity of adverse effects can be increased when Fluvoxamine is combined with Imipramine.	#1E61A5	0.196498977714068	1
Rifabutin	Bupropion	0.214	-Inf	None	1 (0/1)	The metabolism of Bupropion can be increased when combined with Rifabutin.	#1E61A5	0.0982494888570342	1
Rosuvastatin	Gemfibrozil	0.125	-Inf	Major	7 (0/7)	The risk or severity of rhabdomyolysis. myoglobinuria. and elevated creatine kinase (CPK) can be increased when Gemfibrozil is combined with Rosuvastatin.	#1E61A5	0.68774642199924	1
Naltrexone	Buprenorphine	0.238	-Inf	Major	2 (0/2)	The therapeutic efficacy of Buprenorphine can be decreased when used in combination with Naltrexone.	#1E61A5	0.196498977714068	1
Carbamazepine	Verapamil	0.278	-Inf	Major	4 (0/4)	The serum concentration of Carbamazepine can be increased when it is combined with Verapamil.	#1E61A5	0.392997955428137	1
Phenytoin	Megestrol acetate	0.167	-Inf	Moderate	1 (0/1)		#1E61A5	0.0982494888570342	1
Trospium	Biperiden	0.1	-Inf	Moderate	1 (0/1)	The risk or severity of adverse effects can be increased when Biperiden is combined with Trospium.	#1E61A5	0.0982494888570342	1
Rifabutin	Clomipramine	0.059	-Inf	None	1 (0/1)	The metabolism of Clomipramine can be increased when combined with Rifabutin.	#1E61A5	0.0982494888570342	1
Fluvastatin	Gemfibrozil	0.477	-Inf	Major	4 (0/4)	The risk or severity of rhabdomyolysis. myoglobinuria. and elevated creatine kinase (CPK) can be increased when Gemfibrozil is combined with Fluvastatin.	#1E61A5	0.392997955428137	1
Clozapine	Halazepam	0.333	-Inf	Major	1 (0/1)	The risk or severity of adverse effects can be increased when Clozapine is combined with Halazepam.	#1E61A5	0.0982494888570342	1
Diltiazem	Midazolam	0.071	-Inf	Moderate	1 (0/1)	The metabolism of Midazolam can be decreased when combined with Diltiazem.	#1E61A5	0.0982494888570342	1
Captopril	Lithium cation	0.191	-Inf	Moderate	2 (0/2)	The serum concentration of Lithium can be increased when it is combined with Captopril.	#1E61A5	0.196498977714068	1
Warfarin	Fenofibrate	0.278	-Inf	Major	2 (0/2)	Fenofibrate may increase the anticoagulant activities of Warfarin.	#1E61A5	0.196498977714068	1
Repaglinide	Carvedilol	1	-Inf	Moderate	1 (0/1)		#1E61A5	0.0982494888570342	1
Rosiglitazone	Gemfibrozil	1	-Inf	Moderate	1 (0/1)	The metabolism of Rosiglitazone can be decreased when combined with Gemfibrozil.	#1E61A5	0.0982494888570342	1
Verapamil	Nadolol	0.286	-Inf	Major	1 (0/1)	Verapamil may increase the hypotensive activities of Nadolol.	#1E61A5	0.0982494888570342	1
Cyclosporine	Diltiazem	0.111	-Inf	Moderate	1 (0/1)	The metabolism of Cyclosporine can be decreased when combined with Diltiazem.	#1E61A5	0.0982494888570342	1
Theophylline	Phenobarbital	0.027	-Inf	Moderate	1 (0/1)	The metabolism of Theophylline can be increased when combined with Phenobarbital.	#1E61A5	0.0982494888570342	1
Telmisartan	Lithium cation	0.174	-Inf	Moderate	2 (0/2)	The serum concentration of Lithium can be increased when it is combined with Telmisartan.	#1E61A5	0.196498977714068	1
Midazolam	Rifampicin	0.186	-Inf	Minor	2 (0/2)	The metabolism of Midazolam can be increased when combined with Rifampicin.	#1E61A5	0.196498977714068	1
Clozapine	Midazolam	0.417	-Inf	Major	1 (0/1)	The risk or severity of adverse effects can be increased when Midazolam is combined with Clozapine.	#1E61A5	0.0982494888570342	1
Fluoxetine	Rasagiline	0.5	-Inf	Major	1 (0/1)	The risk or severity of adverse effects can be increased when Fluoxetine is combined with Rasagiline.	#1E61A5	0.0982494888570342	1
Carbamazepine	Josamycin	0.058	-Inf	None	3 (0/3)	The metabolism of Carbamazepine can be decreased when combined with Josamycin.	#1E61A5	0.294748466571103	1
Fludrocortisone	Acenocoumarol	0.032	-Inf	None	1 (0/1)		#1E61A5	0.0982494888570342	1
Testosterone	Acenocoumarol	0.104	-Inf	None	3 (0/3)	Testosterone may increase the anticoagulant activities of Acenocoumarol.	#1E61A5	0.294748466571103	1
Cyclosporine	Nabumetone	0.091	-Inf	Moderate	1 (0/1)	Nabumetone may increase the nephrotoxic activities of Cyclosporine.	#1E61A5	0.0982494888570342	1
Chlorthalidone	Lithium cation	0.125	-Inf	Major	1 (0/1)	Chlorthalidone may decrease the excretion rate of Lithium which could result in a higher serum level.	#1E61A5	0.0982494888570342	1
Erythromycin	Triazolam	0.2	-Inf	Moderate	1 (0/1)	The serum concentration of Triazolam can be increased when it is combined with Erythromycin.	#1E61A5	0.0982494888570342	1
Propranolol	Hydralazine	0.062	-Inf	Minor	1 (0/1)	Hydralazine may increase the hypotensive activities of Propranolol.	#1E61A5	0.0982494888570342	1
Pravastatin	Colchicine	0.432	-Inf	Major	2 (0/2)	Colchicine may increase the myopathic rhabdomyolysis activities of Pravastatin.	#1E61A5	0.196498977714068	1
Tizanidine	Quinapril	0.111	-Inf	Major	1 (0/1)	The risk or severity of hypotension can be increased when Tizanidine is combined with Quinapril.	#1E61A5	0.0982494888570342	1
Verapamil	Midazolam	0.136	-Inf	Moderate	1 (0/1)	The metabolism of Midazolam can be decreased when combined with Verapamil.	#1E61A5	0.0982494888570342	1
Colestipol	Hydrocortisone	0.279	-Inf	Moderate	1 (0/1)	Colestipol can cause a decrease in the absorption of Hydrocortisone resulting in a reduced serum concentration and potentially a decrease in efficacy.	#1E61A5	0.0982494888570342	1
Trospium	Olanzapine	0.143	-Inf	Moderate	1 (0/1)		#1E61A5	0.0982494888570342	1
Clozapine	Josamycin	0.1	-Inf	None	1 (0/1)		#1E61A5	0.0982494888570342	1
Morphine	Rifampicin	0.176	-Inf	Moderate	1 (0/1)	The serum concentration of Morphine can be decreased when it is combined with Rifampicin.	#1E61A5	0.0982494888570342	1
Primidone	Methylprednisolone	0.029	-Inf	Moderate	1 (0/1)	The serum concentration of Methylprednisolone can be decreased when it is combined with Primidone.	#1E61A5	0.0982494888570342	1
Cyclosporine	Pyrazinamide	0.105	-Inf	Moderate	1 (0/1)	The serum concentration of Cyclosporine can be increased when it is combined with Pyrazinamide.	#1E61A5	0.0982494888570342	1
Chlorpromazine	Levofloxacin	0.563	-Inf	Moderate	4 (0/4)	Chlorpromazine may increase the QTc-prolonging activities of Levofloxacin.	#1E61A5	0.392997955428137	1
Verapamil	Carvedilol	0.571	-Inf	Major	1 (0/1)	The metabolism of Carvedilol can be decreased when combined with Verapamil.	#1E61A5	0.0982494888570342	1
Verapamil	Phenobarbital	0.231	-Inf	Moderate	1 (0/1)	The metabolism of Verapamil can be increased when combined with Phenobarbital.	#1E61A5	0.0982494888570342	1
Imipramine	Ketoconazole	0.033	-Inf	Moderate	1 (0/1)	The metabolism of Imipramine can be decreased when combined with Ketoconazole.	#1E61A5	0.0982494888570342	1
Lovastatin	Fenofibrate	0.062	-Inf	Major	1 (0/1)	The risk or severity of myopathy and rhabdomyolysis can be increased when Fenofibrate is combined with Lovastatin.	#1E61A5	0.0982494888570342	1
Allopurinol	Mercaptopurine	0.2	-Inf	Major	1 (0/1)	The serum concentration of Mercaptopurine can be increased when it is combined with Allopurinol.	#1E61A5	0.0982494888570342	1
Cyclosporine	Verapamil	0.5	-Inf	Moderate	1 (0/1)	The metabolism of Cyclosporine can be decreased when combined with Verapamil.	#1E61A5	0.0982494888570342	1
Erythromycin	Sirolimus	0.25	-Inf	Major	1 (0/1)	The metabolism of Sirolimus can be decreased when combined with Erythromycin.	#1E61A5	0.0982494888570342	1
Atorvastatin	Bezafibrate	0.308	-Inf	None	1 (0/1)	Bezafibrate may increase the myopathic rhabdomyolysis activities of Atorvastatin.	#1E61A5	0.0982494888570342	1
Pioglitazone	Gemfibrozil	0.48	-Inf	Major	1 (0/1)	The metabolism of Pioglitazone can be decreased when combined with Gemfibrozil.	#1E61A5	0.0982494888570342	1
Doxycycline	Digoxin	1	-Inf	Moderate	2 (0/2)	The metabolism of Digoxin can be decreased when combined with Doxycycline.	#1E61A5	0.196498977714068	1
Cyclosporine	Phenytoin	0.236	-Inf	Moderate	1 (0/1)	The metabolism of Cyclosporine can be increased when combined with Phenytoin.	#1E61A5	0.0982494888570342	1
Cyclosporine	Phenobarbital	0.12	-Inf	Moderate	1 (0/1)	The metabolism of Cyclosporine can be increased when combined with Phenobarbital.	#1E61A5	0.0982494888570342	1
Cyclosporine	Oxcarbazepine	0.476	-Inf	Moderate	2 (0/2)		#1E61A5	0.196498977714068	1
Warfarin	Dexamethasone	0.023	-Inf	Moderate	1 (0/1)	Dexamethasone may increase the anticoagulant activities of Warfarin.	#1E61A5	0.0982494888570342	1
Phenytoin	Tacrolimus	0.075	-Inf	Major	2 (0/2)	The serum concentration of Tacrolimus can be decreased when it is combined with Phenytoin.	#1E61A5	0.196498977714068	1
Omeprazole	Cilostazol	0.451	-Inf	Major	4 (0/4)	The serum concentration of Cilostazol can be increased when it is combined with Omeprazole.	#1E61A5	0.392997955428137	1
Cilostazol	Itraconazole	0.167	-Inf	Major	1 (0/1)	The serum concentration of Cilostazol can be increased when it is combined with Itraconazole.	#1E61A5	0.0982494888570342	1
Rifampicin	Fluvastatin	0.125	-Inf	Moderate	1 (0/1)	The metabolism of Fluvastatin can be increased when combined with Rifampicin.	#1E61A5	0.0982494888570342	1
Digoxin	Rabeprazole	0.276	-Inf	Moderate	1 (0/1)		#1E61A5	0.0982494888570342	1
Clozapine	Norfloxacin	0.076	-Inf	Major	2 (0/2)	Norfloxacin may increase the QTc-prolonging activities of Clozapine.	#1E61A5	0.196498977714068	1
Sirolimus	Clarithromycin	0.085	-Inf	Major	2 (0/2)	The metabolism of Sirolimus can be decreased when combined with Clarithromycin.	#1E61A5	0.196498977714068	1
Imipramine	Terbutaline	0.154	-Inf	Moderate	2 (0/2)	The risk or severity of adverse effects can be increased when Imipramine is combined with Terbutaline.	#1E61A5	0.196498977714068	1
Gemfibrozil	Ursodeoxycholic acid	0.509	-Inf	None	2 (0/2)	The therapeutic efficacy of Ursodeoxycholic acid can be decreased when used in combination with Gemfibrozil.	#1E61A5	0.196498977714068	1
Warfarin	Minocycline	0.042	-Inf	Moderate	1 (0/1)	Minocycline may increase the anticoagulant activities of Warfarin.	#1E61A5	0.0982494888570342	1
Acenocoumarol	Cholestyramine	0.333	-Inf	None	1 (0/1)	Cholestyramine can cause a decrease in the absorption of Acenocoumarol resulting in a reduced serum concentration and potentially a decrease in efficacy.	#1E61A5	0.0982494888570342	1
Disulfiram	Isoniazid	0.454	-Inf	Moderate	4 (0/4)	The risk or severity of adverse effects can be increased when Disulfiram is combined with Isoniazid.	#1E61A5	0.392997955428137	1
Fluorouracil	Metronidazole	0.333	-Inf	Moderate	1 (0/1)	The serum concentration of Fluorouracil can be increased when it is combined with Metronidazole.	#1E61A5	0.0982494888570342	1
Erythromycin	Lovastatin	0.167	-Inf	Major	1 (0/1)	The serum concentration of Lovastatin can be increased when it is combined with Erythromycin.	#1E61A5	0.0982494888570342	1
Phenytoin	Methylprednisolone	0.667	-Inf	Moderate	2 (0/2)	The serum concentration of Methylprednisolone can be decreased when it is combined with Phenytoin.	#1E61A5	0.196498977714068	1
Venlafaxine	Propafenone	0.111	-Inf	Moderate	1 (0/1)	The serum concentration of Venlafaxine can be increased when it is combined with Propafenone.	#1E61A5	0.0982494888570342	1
Atenolol	Repaglinide	1	-Inf	Moderate	1 (0/1)		#1E61A5	0.0982494888570342	1
Doxycycline	Warfarin	0.164	-Inf	Moderate	2 (0/2)	The metabolism of Warfarin can be decreased when combined with Doxycycline.	#1E61A5	0.196498977714068	1
Celecoxib	Warfarin	0.1	-Inf	Moderate	1 (0/1)	Celecoxib may increase the anticoagulant activities of Warfarin.	#1E61A5	0.0982494888570342	1
Amiodarone	Levofloxacin	0.667	-Inf	Major	2 (0/2)	Levofloxacin may increase the QTc-prolonging activities of Amiodarone.	#1E61A5	0.196498977714068	1
Formoterol	Carvedilol	0.165	-Inf	Major	4 (0/4)	Carvedilol may decrease the vasoconstricting activities of Formoterol.	#1E61A5	0.392997955428137	1
Erythromycin	Digoxin	0.5	-Inf	Moderate	1 (0/1)	The metabolism of Digoxin can be decreased when combined with Erythromycin.	#1E61A5	0.0982494888570342	1
Allopurinol	Warfarin	0.353	-Inf	Moderate	1 (0/1)	Allopurinol may increase the anticoagulant activities of Warfarin.	#1E61A5	0.0982494888570342	1
Fluvoxamine	Phenytoin	0.25	-Inf	Moderate	1 (0/1)	The serum concentration of Phenytoin can be increased when it is combined with Fluvoxamine.	#1E61A5	0.0982494888570342	1
Bisoprolol	Repaglinide	0.111	-Inf	Moderate	1 (0/1)		#1E61A5	0.0982494888570342	1
Sirolimus	Itraconazole	0.25	-Inf	Major	1 (0/1)	The serum concentration of Sirolimus can be increased when it is combined with Itraconazole.	#1E61A5	0.0982494888570342	1
Indomethacin	Warfarin	0.25	-Inf	Major	1 (0/1)	Indomethacin may increase the anticoagulant activities of Warfarin.	#1E61A5	0.0982494888570342	1
Doxycycline	Acitretin	0.143	-Inf	Major	2 (0/2)	The risk or severity of adverse effects can be increased when Doxycycline is combined with Acitretin.	#1E61A5	0.196498977714068	1
Rifampicin	Gliclazide	0.3	-Inf	None	1 (0/1)	The serum concentration of Gliclazide can be decreased when it is combined with Rifampicin.	#1E61A5	0.0982494888570342	1
Clozapine	Ciprofloxacin	0.044	-Inf	Major	4 (0/4)	Ciprofloxacin may increase the QTc-prolonging activities of Clozapine.	#1E61A5	0.392997955428137	1
Ketoconazole	Aripiprazole	0.065	-Inf	Moderate	2 (0/2)	The serum concentration of Aripiprazole can be increased when it is combined with Ketoconazole.	#1E61A5	0.196498977714068	1
Doxycycline	Benzylpenicillin	1	-Inf	Moderate	1 (0/1)	The therapeutic efficacy of Benzylpenicillin can be decreased when used in combination with Doxycycline.	#1E61A5	0.0982494888570342	1
Tacrolimus	Rifampicin	0.146	-Inf	Major	2 (0/2)	The serum concentration of Tacrolimus can be decreased when it is combined with Rifampicin.	#1E61A5	0.196498977714068	1
Tacrolimus	Ketoconazole	0.75	-Inf	Major	2 (0/2)	The serum concentration of Tacrolimus can be increased when it is combined with Ketoconazole.	#1E61A5	0.196498977714068	1
Celecoxib	Lithium cation	0.038	-Inf	Major	2 (0/2)	The serum concentration of Lithium can be increased when it is combined with Celecoxib.	#1E61A5	0.196498977714068	1
Atorvastatin	Colchicine	0.15	-Inf	Major	2 (0/2)	The risk or severity of adverse effects can be increased when Colchicine is combined with Atorvastatin.	#1E61A5	0.196498977714068	1
Cyclosporine	Methylphenidate	0.125	-Inf	Minor	1 (0/1)		#1E61A5	0.0982494888570342	1
Ergotamine	Ketoconazole	0.5	-Inf	Major	1 (0/1)	The serum concentration of Ergotamine can be increased when it is combined with Ketoconazole.	#1E61A5	0.0982494888570342	1
Perphenazine	Levofloxacin	0.047	-Inf	Moderate	2 (0/2)		#1E61A5	0.196498977714068	1
Lidocaine	Bisoprolol	0.02	-Inf	Moderate	1 (0/1)	The serum concentration of Lidocaine can be increased when it is combined with Bisoprolol.	#1E61A5	0.0982494888570342	1
Atenolol	Insulin detemir	0.333	-Inf	Moderate	1 (0/1)		#1E61A5	0.0982494888570342	1
Citalopram	Metoprolol	0.105	-Inf	Moderate	1 (0/1)	The serum concentration of Metoprolol can be increased when it is combined with Citalopram.	#1E61A5	0.0982494888570342	1
Triamcinolone	Acenocoumarol	0.063	-Inf	None	2 (0/2)		#1E61A5	0.196498977714068	1
Fentanyl	Itraconazole	0.225	-Inf	Major	2 (0/2)	The serum concentration of Fentanyl can be increased when it is combined with Itraconazole.	#1E61A5	0.196498977714068	1
Phenytoin	Doxycycline	0.08	-Inf	Moderate	2 (0/2)	The serum concentration of Doxycycline can be decreased when it is combined with Phenytoin.	#1E61A5	0.196498977714068	1
Carbamazepine	Isotretinoin	0.064	-Inf	Moderate	1 (0/1)		#1E61A5	0.0982494888570342	1
Haloperidol	Rifampicin	0.333	-Inf	Major	1 (0/1)	The metabolism of Haloperidol can be increased when combined with Rifampicin.	#1E61A5	0.0982494888570342	1
Atenolol	Insulin glulisine	0.333	-Inf	Moderate	1 (0/1)		#1E61A5	0.0982494888570342	1
Ketoconazole	Acenocoumarol	0.25	-Inf	None	1 (0/1)	The serum concentration of Acenocoumarol can be increased when it is combined with Ketoconazole.	#1E61A5	0.0982494888570342	1
Torasemide	Indomethacin	0.5	-Inf	Moderate	1 (0/1)	The therapeutic efficacy of Torasemide can be decreased when used in combination with Indomethacin.	#1E61A5	0.0982494888570342	1
Terbinafine	Acenocoumarol	0.286	-Inf	None	2 (0/2)		#1E61A5	0.196498977714068	1
Bisoprolol	Insulin glulisine	0.111	-Inf	Moderate	1 (0/1)		#1E61A5	0.0982494888570342	1
Ramipril	Lithium cation	0.062	-Inf	Moderate	1 (0/1)	The serum concentration of Lithium can be increased when it is combined with Ramipril.	#1E61A5	0.0982494888570342	1
Warfarin	Metronidazole	0.077	-Inf	Major	1 (0/1)	The serum concentration of Warfarin can be increased when it is combined with Metronidazole.	#1E61A5	0.0982494888570342	1
Ketoconazole	Quetiapine	0.053	-Inf	Major	2 (0/2)	The serum concentration of Quetiapine can be increased when it is combined with Ketoconazole.	#1E61A5	0.196498977714068	1
Meloxicam	Lithium cation	0.037	-Inf	Major	1 (0/1)	The serum concentration of Lithium can be increased when it is combined with Meloxicam.	#1E61A5	0.0982494888570342	1
Indomethacin	Carvedilol	0.148	-Inf	Moderate	1 (0/1)	Indomethacin may decrease the antihypertensive activities of Carvedilol.	#1E61A5	0.0982494888570342	1
Propranolol	Gliclazide	0.25	-Inf	None	1 (0/1)	Propranolol may increase the hypoglycemic activities of Gliclazide.	#1E61A5	0.0982494888570342	1
Ropinirole	Ciprofloxacin	1	-Inf	Moderate	1 (0/1)	The serum concentration of Ropinirole can be increased when it is combined with Ciprofloxacin.	#1E61A5	0.0982494888570342	1
Rifampicin	Bupropion	0.433	-Inf	Moderate	1 (0/1)	The metabolism of Bupropion can be increased when combined with Rifampicin.	#1E61A5	0.0982494888570342	1
Isoniazid	Acenocoumarol	0.304	-Inf	None	1 (0/1)	The metabolism of Acenocoumarol can be decreased when combined with Isoniazid.	#1E61A5	0.0982494888570342	1
Phenytoin	Disulfiram	0.125	-Inf	Moderate	1 (0/1)	The serum concentration of Phenytoin can be increased when it is combined with Disulfiram.	#1E61A5	0.0982494888570342	1
Fluphenazine	Levofloxacin	0.125	-Inf	Moderate	1 (0/1)		#1E61A5	0.0982494888570342	1
Isoniazid	Ketoconazole	0.5	-Inf	Moderate	1 (0/1)	The serum concentration of Ketoconazole can be decreased when it is combined with Isoniazid.	#1E61A5	0.0982494888570342	1
Itraconazole	Ciclesonide	0.083	-Inf	Moderate	1 (0/1)	The metabolism of Ciclesonide can be decreased when combined with Itraconazole.	#1E61A5	0.0982494888570342	1
Theophylline	Ciprofloxacin	0.5	-Inf	Major	2 (0/2)		#1E61A5	0.196498977714068	1
Enalapril	Rifampicin	0.119	-Inf	None	2 (0/2)	The metabolism of Enalapril can be increased when combined with Rifampicin.	#1E61A5	0.196498977714068	1
Haloperidol	Itraconazole	0.625	-Inf	Moderate	2 (0/2)	The metabolism of Haloperidol can be decreased when combined with Itraconazole.	#1E61A5	0.196498977714068	1
Cyclosporine	Norfloxacin	0.167	-Inf	Moderate	1 (0/1)	The metabolism of Cyclosporine can be decreased when combined with Norfloxacin.	#1E61A5	0.0982494888570342	1
Bumetanide	Ibuprofen	0.053	-Inf	Moderate	1 (0/1)	The therapeutic efficacy of Bumetanide can be decreased when used in combination with Ibuprofen.	#1E61A5	0.0982494888570342	1
Bisoprolol	Epinephrine	0.056	-Inf	Moderate	1 (0/1)	Epinephrine may increase the atrioventricular blocking (AV block) activities of Bisoprolol.	#1E61A5	0.0982494888570342	1
Trazodone	Ketoconazole	0.333	-Inf	Moderate	1 (0/1)	The metabolism of Trazodone can be decreased when combined with Ketoconazole.	#1E61A5	0.0982494888570342	1
Terbutaline	Carvedilol	0.064	-Inf	Major	1 (0/1)	Carvedilol may decrease the vasoconstricting activities of Terbutaline.	#1E61A5	0.0982494888570342	1
Amiodarone	Clarithromycin	1	-Inf	Major	1 (0/1)	Clarithromycin may increase the QTc-prolonging activities of Amiodarone.	#1E61A5	0.0982494888570342	1
Methylprednisolone	Ketoconazole	1	-Inf	Major	1 (0/1)	The serum concentration of Methylprednisolone can be increased when it is combined with Ketoconazole.	#1E61A5	0.0982494888570342	1
Erythromycin	Colchicine	0.25	-Inf	Major	1 (0/1)	The serum concentration of Colchicine can be increased when it is combined with Erythromycin.	#1E61A5	0.0982494888570342	1
Phenytoin	Itraconazole	0.2	-Inf	Moderate	1 (0/1)	The serum concentration of Itraconazole can be decreased when it is combined with Phenytoin.	#1E61A5	0.0982494888570342	1
Moxifloxacin	Acenocoumarol	0.067	-Inf	None	1 (0/1)		#1E61A5	0.0982494888570342	1
Tizanidine	Lisinopril	0.125	-Inf	Major	1 (0/1)	Tizanidine may increase the hypotensive activities of Lisinopril.	#1E61A5	0.0982494888570342	1
Erythromycin	Rifampicin	0.5	-Inf	Moderate	1 (0/1)	The metabolism of Erythromycin can be increased when combined with Rifampicin.	#1E61A5	0.0982494888570342	1
Ranitidine	Ketoconazole	1	-Inf	Moderate	1 (0/1)	The serum concentration of Ketoconazole can be decreased when it is combined with Ranitidine.	#1E61A5	0.0982494888570342	1
